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Abstract  
Protein-protein interaction networks provide a global picture of cellular function and 
biological processes. Some proteins act as hub proteins, highly connected to others, whereas 
some others have few interactions. The dysfunction of a single highly connected interactor 
can cause widespread disruption of cellular processors including diseases and cancer. 
Therefore, detailed study of the interactions made by cancer-related proteins will help explain 
their role in the interaction networks.  
 
The investigation of proteins by mass spectrometry (MS) has provided unique opportunities 
to gain insight into the dynamics of these proteins at the molecular level.  MS uses mass 
analysis for protein characterization, and is currently the most comprehensive and versatile 
tool in proteomics. MS can provide confirmation of protein samples of interest, accurate 
molecular mass measurements of proteins, purity of protein samples, detection of post-
translational modifications, and more recently, interactions between two or more proteins.  
 
The conventional way of investigating the structure of proteins involves nuclear magnetic 
resonance (NMR) or X-ray crystallography. Compared to MS these methods are time 
consuming methods and, furthermore, require a considerable amount of protein. MS has 
proved to be useful in this regard as it provides insights into the structural arrangement of 
proteins, and/or their interacting partners, without the need for crystalliastion or the tedious 
process of backbone assignment before structural and functional annotations can be attributed 
to the protein of interest. However, in many cases, conventional methods are used parallel to 
MS to serve as validation of the MS data.   
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The broad objective of this MSc study was to provide structural and functional insights into 
the function of Retinoblastoma Binding Protein-6 (RBBP6), using a MS approach. The aims 
were twofold: 1) to investigate metal ion binding by RING (Really Interesting New Gene) 
finger domains from RBBP6, and 2) to investigate the in vitro interaction between RBBP6 
and Hsp 70(Heat Shock Protein 70), and between RBBP6 and Murine Double Minute-2 
(Mdm2).  
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Figure 1.1. During electrospray ionization the sample is dissolved in a polar, volatile solvent 
and pumped through a narrow, stainless steel capillary. The charged droplets 
diminish in size by solvent evaporation, assisted by a warm flow of nitrogen 
known as the drying gas, which passes across the front of the ionization source. 
Charged sample ions, free from solvent, are then released from the droplets into 
the analyzer of the mass spectrometer. (Figure taken from Steen and Mann 
2004). 
Figure 1.2. In MALDI the sample to be analyzed is spotted onto an ultraviolet- absorbing 
matrix, which is normally a low-molecular-weight aromatic acid. On irradiation 
with a focused laser beam of the appropriate wavelength, the matrix molecules 
sublimate and transfer the embedded non-volatile analyte molecules into the gas 
phase. After numerous ion–molecule collisions in the plume of ions and 
molecules, singly protonated analyte ions are formed, which are accelerated by 
electric potentials into the mass analyzer of choice. Figure taken from Steen and 
Mann (2004). 
Figure 1.3. Products generated from a cross-linking reaction followed by proteolytic 
digestion. Type 2 cross-links (inter cross-links) are the cross-links most desired 
during protein-protein interaction experiments. (Figure taken from Leitner et al. 
2010). 
Figure 1.4. Most common ion fragments seen under low-energy conditions. CID, a low-
energy fragmentation method gives rise to N-terminal ‘b-ions’ or C-terminal ‘y-
ions.’ Figure taken from Schilling et al. (2003). 
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Figure 1.5. Fragmentation spectrum of a cross-linked peptide. The fragment peaks are 
annotated depending on the peptide that fragmented and the naming convention for 
peptides. The spectrum features fragments of both cross-linked peptides, thereby 
leading to confident and unambiguous identification of both peptides. Figure taken 
from Rappsilber (2011). 
Figure 1.6. Domain organization of the RBBP6 protein family. All homologues contain a 
DWNN domain, a zinc knuckle and a RING finger and are found in all complete 
eukaryotic genomes analyzed to date. (Taken from Pugh et al. 2006). 
Figure 1.7.  Schematic representation of a RING finger domain indicating the ‘cross-brace’ 
topology for zinc ion coordination (Figure taken from Chasapis et al. 2009). 
Figure 1.8. The ubiquitin pathway. A hierarchical set of three types of enzyme is required for 
substrate ubiquitination: ubiquitin-activating (E1), ubiquitin-conjugating (E2) and 
ubiquitin-protein ligase (E3) enzymes. 
Figure 1.9. Alignment of RING finger domains from RBBP6 orthologues suggests that the 
HsRING finger binds 2 Zn
2+
ions, in which 1
st
 and 3
rd
 pair of cysteine residues (red 
arrows) bind one Zn
2+
 and the 2
nd
 and 4
th
 pairs (blue arrows) the other. The alignment 
reveals a disruption in the 1
st
 pair of coordinating cysteines in the AnRING and 
ScRING homologs. The alignment reveals that some of the residues coordinating the 
first Zn
2+
 ion (red arrows) are missing from A. niger and S. cerevisiae, raising the 
possibility that both of these orthologues may bind only one Zn
2+
 ion. 
Figure 3.1. (a) Primers designed for the amplification of S. cerevisiae included BamHI and 
XhoI restriction sites (bold) in the forward and reverse primers respectively, as well 
as two stop codons (underlined) immediately upstream of the XhoI site. (b) The A. 
niger sequence synthesized by Genscript Inc. was flanked by BamHI and XhoI sits. A 
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single stop codon was added immediately upstream of the XhoI site. (c) The A. niger 
sequence was optimized by Genscript Inc. to increase the efficiency of expression in 
E. coli. Primers were synthesized by the DNA synthesis facility at the University of 
Cape Town.  
Figure 3.2. Amplification and cloning of the RING finger domain from S. cerevisiae. a) 
ScRING amplified directly from genomic DNA yielded the expected product of 267 
bp (lanes 2 and 4). Lanes 1 and 3 contained no template DNA. b) Following colony 
PCR the 267bp fragment corresponding to the ScRING validated the successful 
cloning of the gene into the pGEX-6P-2 expression vector. Lanes 2, 3, 4, 7, 9, 10 
correspond to positive clones. Lane 1 is the negative control for the PCR reaction as it 
contains no template DNA. 
Figure 3.3. Sub-cloning of the RING finger domain from A. niger into pGEX-6P-2. a) A 252 
bp fragment corresponding to the gene of interest was released when the pUC57-
AnRING was digested with BamHI and XhoI. (b) The A. niger RING was 
successfully sub-cloned into pGEX-6P-2, as confirmed by the presence of a 252 bp 
fragment, following digestion of plasmid DNA extracted from positive clones. Lanes 
1, 3 and 5 represent positive clones. 
Figure 3.4. Experimentally determined sequences (Sbjct) for ScRING (a) and AnRING (b) 
were in 100 % agreement with expected sequences (Query). Flanking restriction 
sequences GGATCC (BamHI) and CTCGAG (XhoI) are indicated in yellow. 
Figure 3.5. Pure samples of GST-RING finger proteins from S. cerevisiae (a), A. niger (b) 
and H. sapiens (c) were eluted from the glutathione matrix following addition of 20 
mM free glutathione. All three domains exhibit an apparent molecular weight of 
approximately 35 kDa, as expected, corresponding to 26 kDa (GST) plus 9 kDa 
(RING). 
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Figure 3.6. Successful cleavage with 3C protease and separation using glutathione affinity of 
GST-RING proteins from S. cerevisiae (a), A. niger (b) and H. sapiens (c). In each 
case the uncleaved fusion can be seen in lane 1 and the cleaved sample in lane 2. Lane 
3 and upward show varying degrees of successful separation of GST from the RING 
finger using a second round of glutathione affinity chromatography. 
Figure 3.7. Chromatogram and SDS-PAGE showing the successful purification of the 
HsRING finger domain. Subjecting the sample to size exclusion chromatography 
seperates most of the GST from the RING, to an extent that minimal GST remains in 
the sample. 
Figure 3.8. 1D 
1
H spectrum of S. cerevisiae RING finger domain at pH 6.0, 25 °C recorded 
at 600 MHz. The large chemical shift dispersion of resonances and sharp peaks 
exhibited by the protein is indicative of its foldedness.  This is confirmed by the 
appearance of resonances corresponding to amide protons (H
N
) in the region 9-11 
ppm, α-protons (Hα) in the region 5-6 ppm, and methyl groups in the region 0-0.5 
ppm. The sharpness of the peaks also indicate that the protein is monomeric. 
Figure 3.9 
15
N-HSQC spectrum of a 10x diluted ScRING (red) superimposed over the 
concentrated sample (black). Spectra were recorded at pH 6.0, 25C at 600MHz. The 
absence of concentration-dependent chemical shift perturbations suggests that the 
domain is monomeric in solution. 
Figure 3.10 1D 
1
H spectrum of the A. niger RING finger domain at pH 6.0, 25 °C, recorded 
at 600 MHz. The high level of dispersion (some H
N
 resonances in the region 9-10 
ppm, some H
α
 in the region 5-6 ppm and methyl protons in the region 0-0.5 ppm) is 
an indication that the protein is folded. 
Figure 3.11. Deconvoluted ESI MS of Homo sapiens RING finger. a) The denaturing ESI 
spectrum reveals the protein to be 10230 Da when the protein is sprayed into the 
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mass spectrometer using formic acid. b) The non-denaturing spectrum reveals the 
most abundant species to be the HsRING with 2 Zn
2+
 bound. c) The dimer with no 
Zn
2+ 
bound, the dimer with 2 Zn
2+ 
and the dimer binding 4 Zn
2+
. The other peaks are 
separated by approximately 22 Da and are likely to correspond to sodium adducts, 
which is a result of the protein being insufficiently desalted prior to MS 
Figure 3.12. Deconvoluted ESI MS of Saccharomyces cerevisiae RING finger. a.)The 
denaturing spectrum indicates the protein with no Zn
2+ 
ions bound at 9610 Da. b) The 
non-denaturing spectrum reveals the most abundant species at the peak of 9673 Da, 
indicative of the one Zn
2+
 ion bound to the protein. Traces of the protein with no Zn
2+
 
bound were also present. 
Figure 3.13. Deconvoluted ESI MS of Aspergillus niger RING finger.  a.)The denaturing ESI 
spectrum indicates the protein with no Zn
2+ 
ions bound at 9200 Da. b.) The no-
denaturing spectrum reveals majority of the species binding 2 Zn
2+
. A peak 
corresponding to the protein binding 1 Zn
2+
 could not be detected. 
Figure 4.1. The N-terminal of RBBP6 interacts with Hsp 70. (A) In a 6-His affinity pull-
down assay, 6His-tagged Hsp70 was able to precipitate a GST-DWNN fusion protein 
(lane 3), but two unrelated His- tagged proteins were not (lanes 1-2). The same 
amount of DWNN fusion protein was present in each lane. (B) In the reciprocal GST-
affinity pull-down assay, GST-DWNN and a larger fragment of RBBP6 (including 
DWNN), were able to precipitate 6His-tagged Hsp70 (lanes 2-3), but an unrelated 
GST-fusion protein was not (lane 1) (Kappo et al. 2012).  
Figure 4.2. Analysis of cross-linked species. a) SDS-PAGE following cross-linking of 
DWNN and Hsp 70. b) Western blot of cross-linking assay using monoclonal anti-
DWNN antibody. The addition of the hetero-bifunctional cross-linker sulfo-MBS 
creates high molecular weight bands that exceed the molecular weight of Hsp70 (70 
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kDa). These do not correspond to Hsp70-Hsp70 complexes because the antibody 
does not recognize Hsp70 at all (lane 2) nor to DWNN-DWNN complexes as they do 
not appear to any significant content in lane 4, where DWNN alone is cross-linked. 
Figure 4.3. Intra-cross-links identified by Mass Matrix.  Data generated from the Mass 
matrix server using the cross-linking application identified Hsp70 whilst no evidence 
of DWNN was observed, thus revealing intra-cross-links between the Hsp70 protein 
rather than inter-cross-links with DWNN.  
Figure 4.4. Isolation of an interacting complex between the DWNN domain and Hsp70. (a) 
Size exclusion chromatogram of Hsp70 alone. (b) Size exclusion chromatogram of 
DWNN and Hsp70. The labels refer to the lanes in (c). (c) SDS-PAGE of fractions 
corresponding to the fractions indicated in (b). The small peak eluting prior to Hsp70 
contains a band consistent with the DWNN domain (lanes 3 and 4), which is see on its 
own in lane 1. The bulk of the DWNN domain elutes much later, consistent with its 
molecular weight of only 9 kDa.  
Figure 4.5. Identification of DWNN from excised band. Using the database as the input the 
MASCOT server identified mainly keratin and trypsin (a), which are a result of 
sample preparation prior to MS. However, peptides identified match that of the 
RBBP6 gene. When subjecting the server to the DWNN domain sequence as input (b) 
the server identified peptides covering 68 % of the DWNN domain sequence 
(highlighted in green). 
Figure 4.6. Primer design for GST-MDM2-RING incorporating BamHI and XhoI restriction 
sites (red rectangles). Stop codon sites are indicated by the green rectangle. 
Figure 4.7. (a) Primers for amplification of MDM2-RING, incorporating an N-terminal NdeI 
and a C-terminal XhoI site (red boxes) as well as two stop codons immediately 
following the end of the gene. (b) Cloning into the NdeI and XhoI sites was chosen so 
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as to incorporate an N-terminal 6His tag. Incorporation of a C-terminal 6His tag was 
obviated by the stop codons incorporated into the reverse primer. Figure adapted from 
http://www.staff.ncl.ac.uk/p.dean/pET.pdf, accessed 04/07/2013. 
Figure 4.8.  a) Colony PCR screen of putative clones identified one positive colony (lane 2), 
which was subjected to sequencing. b) Comparison of the experimental sequence 
(Query) showed that the construct contained a mismatch (indicated in green). 
Inspection of the sequencing trace (c) confirmed that the mismatch was indeed 
present and was not due an error in base calling. Fortunately the mismatch was found 
to have no effect on the amino acid sequence. 
Figure 4.9. GST-affinty pulldown assay using GST-RBBP6-RING as bait and MDM2-
RING-6His as prey. MDM2 RING finger was probed for using a monoclonal 
antibody against the full length MDM2 protein. GST-RBBP6-RING is able to 
precipitate 6His-MDM2-RING, but a dummy GST-fusion was not. 
Figure 4.10. Immunoprecipitation of MDM2-RING-6His and RBBP6-RING. Using an affi-
gel matrix to couple antibodies to a matrix RBBP6-RING finger was used as bait to 
pull down MDM2-RING--6His finger. MDM2 RING was probed for using a 
monoclonal antibody against the full length MDM2 protein. b) Using MDM2-RING-
6His as bait the RBBP6-RING was precipitated, as detected using a polyclonal 
antibody against the RBBP6-RING finger. 
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Chapter 1: Literature review 
1.1 Introduction 
Really Interesting New Gene proteins, more commonly known as RING finger domains, 
are small motifs of 70 amino acids in length that stabilize themselves by binding two zinc 
ions (Dominguez et al. 2004). The zinc ions are coordinated by eight cysteine or histidine 
residues in a so-called cross-brace fashion, in which the first and third pair of 
coordinating residues in the sequence coordinate one zinc ion, while the second and 
fourth pair coordinate the second zinc ion. RING finger domains are hallmarks of E3 
ubiquitin ligase enzymes, which catalyze the attachment of ubiquitin moieties to substrate 
proteins. U-box domains adopt a similar structure to that of RING finger domains, 
although they do not bind any zinc ions, with the stability deficit being made up by 
increased numbers of hydrogen bonds and salt bridges. Retinoblastoma binding protein 6 
(RBBP6) is a 250 kDa human RING finger-containing protein that has been shown to be 
involved in the regulation of mRNA processing and apoptosis, among other functions (Li 
et al. 2007). It has also been shown to function as an E3 ubiquitin ligase, ubiquitinating 
both p53 and Y-Box Binding Protein 1 (YB-1) through its RING finger domain (Li et al, 
2007, Chibi et al, 2008). NMR studies of the RING finger domain of human RBBP6 has 
confirmed that it binds two zinc ions (Kappo et al, 2012). However, analysis of the 
sequences of orthologues from other organisms reveals that in some of them, including 
the yeast Saccharomyces cerevisiae, some of the zinc coordinating residues have been 
replaced by residues that are unable to coordinate zinc. The conclusion to be drawn is that 
the RING finger in S. cerevisiae RBBP6 (ScRBBP6) binds only one zinc ion. If so, this 
may be the first report of a single-zinc RING finger domain. 
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If the resulting protein were folded, it would suggest that the requirement for binding one 
of the zinc ions has been replaced by the same mechanisms that stabilize U-boxes. The 
domain may therefore represent an intermediate between RING fingers and U-boxes. This 
is interesting in view of the fact that, based on their amino acid sequences, the RING 
fingers from the RBBP6 family bear strong similarities to U-boxes (Aravind and Koonin. 
2000), an observation which is supported by the 3-dimensional structure of the human 
RING finger (Kappo et al. 2012). In RING fingers from other members of the RBBP6 
family, such as that from the fungus Aspergillus niger, one of the zinc coordinating 
residues has been replaced by an aspartic acid (Kappo et al, 2012).  
 
Non-denaturing mass spectrometry represents another technique for studying the zinc 
binding of proteins that is potentially much more convenient, rapid, as well as requiring 
much less sample. However protein mass spectrometry is conventionally performed under 
denaturing conditions, resulting in unfolding of the protein and loss of any bound zinc. 
Analysis of zinc binding cannot be performed under denaturing conditions. Even in native 
conditions there is a high probability of bound zinc being lost during ionization, unless 
very soft ionisation conditions are used. In recent years mass spectrometry using soft 
electro-spray ionisation and volatile solvents such as ammonium acetate has been shown 
to be suitable for studying the folded native state of a number of proteins, including zinc 
binding and protein-protein interactions (Benesch and Robinson. 2006). One of the aims 
of this project was therefore to use non-denaturing mass spectrometry to investigate the 
number of zinc ions bound by RING finger domains from the RBBP6 protein family. 
 
Although possible, investigation of protein-protein interactions using non-denaturing 
mass spectrometry has proved to be highly demanding from a technical point of view. An 
alternative method involves stabilization of non-covalent complexes using covalent cross-
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linking reagents. The attachment points of these cross-links can then be determined using 
conventional mass spectrometry, by trypsinizing the complex and using tandem mass 
spectrometry under denaturing conditions to identify cross-linked fragment from both 
proteins. A second aim of the project was to test this method using previously identified 
interactions involving human RBBP6. These included the interaction between the N-
terminal DWNN domain of RBBP6 and the Heat shock protein 70 (Hsp70), and between 
the RING finger domain of RBBP6 and Murine Double Minute 2 (MDM2), better known 
for its ubiquitination and suppression of the major tumour suppressor protein p53. In 
order to do that, suitable interacting fragments first had to be expressed in bacteria and 
shown to interact in vitro using other methods, principally immunoprecipitation. Hence a 
third aim was to express the RING and DWNN domains from human RBBP6 and 
domains from Hsp70 and MDM2 in bacteria, and use immunoprecipitation to confirm the 
interactions in vitro. 
The following subsections in this chapter shed some light on the history and 
advancements made in both non-denaturing, and denaturing mass spectrometry, ionisation 
techniques, as well as cross-linking MS, to investigate protein-protein interactions. It then 
focuses on the RBBP6 family of proteins, particularly RING finger domains, that are 
involved in many processes, including ubiquitination and pre-mRNA processing. 
 
1.2 Mass spectrometry 
The development of mass spectrometry (MS) has had a profound influence on the study 
of proteins and protein function (Aebersold and Mann. 2003). The classical proteomic 
quantification methods using dyes, fluorophores or radioactivity provided very good 
sensitivity, linearity, and dynamic range, but they suffered from two important 
shortcomings: i) they required high-resolution protein separation, not typically provided 
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by 2-dimensional (2-D) gels, which limited their applicability to abundant and soluble 
proteins, and ii) they could not reveal the identity of any particular protein (Bantscheff et 
al. 2007).  Protein sequencing was carried out using Edman degradation, in which 
polypeptides underwent chemical step-wise degradation from the N-terminus to the C-
terminus (Domon and Aebersold. 2006), followed by amino acid identification using 
ultraviolet (UV) spectroscopy. This required a free amino terminus on the protein of 
interest, and relied on the fact that degradation cannot be blocked upon the Edman 
reaction (Steen and Mann. 2004).  During the 1990s mass spectrometry, in which 
biomolecules are ionized and their mass measured by following their specific trajectories 
in a vacuum system, displaced Edman degradation, because it is much more sensitive and 
can fragment the peptides in seconds instead of hours or days (Steen and Mann. 2004). 
Today MS has established itself as the primary method of protein identification from 
complex mixtures of biological origin (Baldwin. 2004) and has become the powerhouse 
behind the development of proteomics.  It is seen as a powerful analytical tool that 
elucidates many characteristics of a protein sample, including confirmation of a sample of 
interest, molecular weight determination of the protein sample, purity of the sample, 
detection of post-translational modifications (PTMs), disulfide bridge determination and, 
more recently, protein-protein interactions. The identification of proteins, which are often 
drug targets and are present at low concentration levels in complicated mixtures, is 
significantly facilitated by the sensitivity of MS (Glish and Vachet. 2003). In combination 
with separation techniques such as liquid chromatography, MS can play an important role 
in identifying and monitoring biomarkers in physiological fluids, which is a useful way of 
assessing drug efficacy and safety issues (Glish and Vachet. 2003). 
 
 
 
 
 
 5 
1.2.1 Sample preparation 
MS is based on producing, differentiating and detecting ions in the gas phase (Siuzdak et 
al. 1994). Mass spectrometry was restricted for a long time to small and thermo-stable 
compounds because of the lack of effective techniques to softly ionize and transfer the 
ionized molecules from the condensed phase into the gas phase without excessive 
fragmentation (Domon and Aebersold. 2006).  
 
Identification of proteins is based on the analysis of peptides generated by proteolytic 
digestion (Baldwin. 2004).  Proteins, being very unpredictable (solubility, 
oligomerization), first have to be converted to peptides before they can be introduced into 
the mass spectrometer. The most commonly used enzyme for the conversion of proteins 
to peptides is trypsin, an aggressive and stable protease which specifically cleaves 
proteins on the carboxy-terminal side of arginine and lysine residues (Steen and Mann. 
2004). 
1.2.2 Ionization 
The most important reaction to occur in MS is the conversion of the analyte of interest 
into gas phase ions (Glish and Vachet. 2003). Previous ionization strategies were only 
suitable for low molecular weight, thermally stable compounds; proteins and peptides, on 
the other hand, are polar, nonvolatile and thermally unstable species that require an 
ionization technique that transfers an analyte into the gas phase without extensive 
degradation (Yates et al. 2009).   
 
The emergence of two soft ionization techniques in the 1980s made it possible for 
proteins and peptides to be analyzed. Electrospray ionization (ESI) and matrix-assisted 
laser desorption/ionization (MALDI) are the two techniques most commonly used to 
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volatize and ionize the peptides for mass spectrometric analysis (Aebersold and Mann. 
2003). The ionization techniques are described as ‘soft’ because they are able to generate 
ions from large, nonvolatile analytes such as proteins and peptides without significant 
analyte fragmentation (Aebersold and Goodlett. 2001).  The development of these two 
techniques has revolutionized the field of biological MS, leading to the award in 2002 of 
the Nobel Prize in chemistry to John Fenn and Koichi Tanaka.  
a) Electrospray Ionization (ESI) 
ESI is well suited to the analysis of polar molecules ranging from less than 100 daltons 
(Da) to more than 1 000 000 Da in molecular mass. Ions are generated at atmospheric 
pressure by passing a solution-based sample through a small capillary at a potential 
difference relative to a counter electrode (Glish and Vachet. 2003). This results in the 
formation of an electrically charged spray, which is followed by formation and 
desolvation of analyte-solvent droplets (Yates et al. 2009).  Through the application of a 
drying gas (usually N2) or heat, the solvent evaporates and the droplet size decreases, 
resulting in the formation of desolvated ions (Fig. 1.1). A characteristic of electrospray 
ionization is the formation of highly charged ions without fragmentation (Yates. 1998). 
While the ESI process is tolerant to low levels of buffers, salts and detergents, these 
substances can form adducts with the analyte, causing ambiguous molecular mass 
determination; they can also suppress the formation of analyte ions (Yates. 1998). 
Positive attributes of ESI favouring it for biological samples are the lack of a limit to the 
size of the molecule that can be ionized, as well as the ‘soft’ ionization of the technique 
that allows for the ionization of intact non-covalent biomacromolecular complexes (Glish 
and Vachet. 2003), thereby making MS a perfect tool for the elucidation of protein-
protein interactions. The downsides to ESI include that sample is constantly being 
consumed, and its susceptibility to ion suppression effects (Glish and Vachet. 2003).  
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Figure 1.1 During electrospray ionization the sample is dissolved in a polar, volatile solvent and 
pumped through a narrow, stainless steel capillary. The charged droplets diminish in size by 
solvent evaporation, assisted by a warm flow of nitrogen known as the drying gas, which passes 
across the front of the ionization source. Charged sample ions, free from solvent, are then released 
from the droplets into the analyzer of the mass spectrometer. (Figure taken from Steen and Mann 
2004). 
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Because proteins are identified by the m/z (mass-to-charge) ratios of their peptides and 
fragments, a high level of separation is required for accurate protein identification (Yates 
et al. 2009). High-pressure liquid chromatography (HPLC) is usually directly coupled to 
instruments with an ESI source, as the continuous separation via HPLC is compatible  
with the continuous ionization source provided by ESI (Yates et al. 2009).  Examples of 
HPLC chromatographic materials commonly used in MS-based proteomics include ion 
exchange, reverse phase, affinity, and hybrid material, with high-pressure reverse phase 
chromatography being the most favoured (Steen and Mann. 2003).  
b) Matrix-Assisted Laser Desorption/Ionization (MALDI) 
In MALDI ions are produced by pulsed-laser irradiation of the sample of interest (Glish 
and Vachet. 2003), following adsorption onto a matrix.. The matrix, typically a UV-
absorbing weak organic acid, absorbs laser energy and transfers it to the acidified analyte, 
causing desorption of ions of the analyte into the gas phase (Yates et al. 2009). Because 
the analyte is incorporated into a matrix during crystallization (Fig. 1.2), the process may 
serve to sequester the analyte from contaminants such as salt and buffers, in addition to 
direct excitation (Yates. 1998). The ions generated from MALDI are predominantly 
singly charged (Yates et al. 2009), providing a one-to-one correspondence between ions 
in the mass spectrum and the masses of peptides in the mixture (Yates. 1998).  Compared 
to ESI, very little sample is wasted, thereby achieving very high levels of sensitivity 
(Glish and Vachet. 2003). However, one of the drawbacks to MALDI is the large degree 
of chemical noise generated by the matrix, making low molecular weights difficult to 
analyze. 
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Figure 1.2 In MALDI the sample to be analyzed is spotted onto an ultraviolet- absorbing matrix, 
which is normally a low-molecular-weight aromatic acid. On irradiation with a focused laser 
beam of the appropriate wavelength, the matrix molecules sublimate and transfer the embedded 
non-volatile analyte molecules into the gas phase. After numerous ion–molecule collisions in the 
plume of ions and molecules, singly protonated analyte ions are formed, which are accelerated by 
electric potentials into the mass analyzer of choice. Figure taken from Steen and Mann (2004). 
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1.2.3 Mass Analyzers 
Mass analyzers are differentiated as being either beam analyzers, or trapping analyzers; in 
the former ions leave the source in a beam and pass through the analyzing field to the 
detector, whilst the latter traps ions in the analyzing field after being formed in the 
analyzer itself or being injected from an external source (Glish and Vachet. 2003).  Mass 
analyzers form an integral part of MS instrumentation as they are able to store ions and 
separate them based on m/z ratios (Yates et al. 2009).  Each mass analyzer possesses 
unique qualities, including mass range, analysis speed, resolution, sensitivity, and 
dynamic range.  
a) Ion trap 
These are robust, sensitive, inexpensive analyzers, in which ions are captured or ‘trapped’ 
for a certain period of time, and are then subjected to MS or MS/MS (tandem MS) 
analyses (Siuzdak et al. 1994). MS/MS is the ability to induce fragmentation and perform 
successive MS experiments on the fragmented ions (Yates et al. 2009). Drawbacks of 
traditional ion-trap analyzers include a relatively low mass accuracy, which has been 
overcome in recent years by the development of 2D and 3D ion traps. Ion trap analyzers 
have evolved since their introduction, with the LTQ ion trap being the recent 
advancement in the field (Schwartz et al. 2002). Features of the instrument include a ten-
fold higher storage capacity than 3D ion traps, and high resolution at a faster scanning 
rate (Yates et al. 2009). The instrument is ideally suited for bottom-up liquid 
chromatography LC/MS protein identification from complex mixtures (whole-cell 
lysates). 
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The LTQ Orbitrap is a hybrid MS instrument that incorporates recent advances in ion-trap 
development, where it is used for trapping, ion selection, and ion reactions (Yates et al. 
2009). It uses the orbital trapping of ions in its static electrostatic fields in which the ions 
orbit around a central electrode and oscillate in an axial direction (Yates et al. 2009). The 
orbitrap mass analyzer features high resolution, high mass accuracy, and great dynamic 
range. When coupled to an LTQ ion trap, the instrument offers the high resolution and 
mass accuracy of the orbitrap, combined with the speed and sensitivity of the LTQ ion 
trap (Yates et al. 2009). 
b) Time-of-flight (TOF) 
TOF analyzers are the simplest of mass analyzers.  Ions exiting the ion source are 
accelerated through a fixed potential before travelling a fixed distance and striking the 
detector (Glish and Vachet. 2003). The time it takes for an ion to reach the detector is 
related to its mass-to-charge (m/z) ratio (Yates. 1998). The addition of an electrostatic 
mirror (reflectron) at the end of the flight tube increases the resolution of TOF 
spectrometry by compensating for small differences in the velocities of ions with the 
same m/z. The mass range of TOF instruments is therefore vast (Glish and Vachet. 2003). 
c) Quadrupole 
Quadrupole mass separation is a result of ion motion in a dynamic electric field and is 
directly dependent on the m/z of the ion (Glish and Vachet. 2003). The electric fields are 
created by simultaneously applying a direct current voltage and an oscillating voltage on 
four parallel metal rods, known as quadrupoles (Yates. 1998). Quadrupole mass filters are 
usually coupled together, thereby allowing for detailed structural information to be 
inferred (Steen and Mann. 2004). This is achieved by creating a reaction region between 
two quadrupoles, known as a gas-phase collision cell (Yates. 1998). The benefit of this 
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collision cell is the ability to re-focus ions scattered from collisions with neutral gases, 
thereby allowing for efficient fragmentation (Yates et al. 2009).   
 
1.3 Analysis of protein-metal ion binding using mass spectrometry 
Advances in mass spectrometry have opened up new opportunities for the study of 
proteins. The development of non-denaturing MS methods has allowed for proteins to be 
studied in their folded state, opening up the fields of protein-metal ion and protein-protein 
interactions to MS. Non-denaturing (native) MS provides a direct and accurate 
measurement of the metal-binding stoichiometry of a protein, based on an observed shift 
in the mass of a protein arising from the non-covalent binding of the metal ion (Veenstra. 
1999). Since its introduction, ESI has been successfully employed to investigate various 
non-covalently bound protein complexes (Gehrig et al. 2000). Advancements in ESI have 
produced narrower mass spectrum peaks and lower charge states, thereby producing more 
‘native-like’ conformations (Benesch & Robinson. 2006). Today, native ESI-MS has 
become the method of choice for the elucidation of protein assemblies (Zhang et al. 
2011), which provides a suitable platform for studying protein-metal ion coordination, as 
the intact protein survives the desolvation and ionization process and is transferred intact 
into the gas phase (Stengel et al. 2012). It is a rapid, sensitive technique that can provide 
invaluable information on bound small molecules (Laganowsky et al. 2013). 
 
1.4 Analysis of protein-protein interactions using mass spectrometry 
Characterization of non-covalent protein interactions poses an extremely challenging task 
for the reasons that many protein interactions are not stable, most interactions are 
transient, and multi-protein complexes possess no common factors or physical properties 
that can be used as an analytical handle (Tang et al. 2005).  Protein-protein interactions 
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constitute the metabolic and signaling pathways that control the growth and development, 
structure, operation, replication, and selective elimination of cells (Figeys et al. 2001). In 
the past, non-covalent protein-protein interactions were analyzed using fluorescence, 
circular dichroism (CD) and UV (Veenstra. 1999). These techniques all require 
meticulous concentration measurements and rely on a change in the signal originating 
from one of the proteins as it is titrated with the other interacting protein (Veenstra. 
1999). The use of MS for interactions provides direct and unambiguous results that are 
not influenced by concentration measurements (Figeys et al. 2001).  Although MS, unlike 
NMR and X-ray crystallography, cannot provide atomic level resolution, it does have 
advantages when interrogating protein complexes (Zhang et al. 2011). MS of intact 
soluble protein complexes has emerged as a powerful technique to study the 
stoichiometry, structure-function and dynamics of protein assemblies (Laganowsky et al. 
2013). A major advantage of studying protein-protein interactions using MS is the facility 
to detect different species within the same solution, even when their masses are very 
similar (Benesch & Robinson. 2006). The use of chemical cross-linkers together with MS 
provides a robust platform for protein-protein interaction analysis, which will be 
discussed further. 
 
The first step is to generate a complex between the proteins under scrutiny. This can be 
achieved using Size Exclusion Chromatography (SEC), in which the interacting proteins 
are incubated together, passed thought the SEC column, and eluted as pure complex 
fractions. Non-covalent interactions are then made covalent through the addition of a 
cross-linker, followed by SDS-PAGE to isolate the intact complex, Under the denaturing 
conditions used in SDS-PAGE, cross-linked complexes appear as newly-formed bands of 
higher molecular mass; bands of interest are excised from the gel and subjected to 
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digestion in-gel using trypsin. Resulting peptides are submitted for MS analysis, and 
resulting masses are analyzed using software designed to identify cross-linked products. 
Subjecting these peptides to peptide mass fingerprinting or other identification methods 
reveals the identity of the linked polypeptides (Back et al. 2003).  
 
Cross-linking MS (CXMS) can also be employed for structural analysis, providing 
significant advantages over conventional methods even in the more challenging cases 
(Rappsilber. 2011).  It provides data on the tertiary and quaternary structure of proteins in 
their native state (Rappsilber. 2011), is fast and economical, and supports homology 
modeling (Chen et al. 2011).  
 
A cross-linker is typically composed of a linear molecule with a reactive group at each 
end, separated by a spacer (Sinz. 2006).  Reactive groups target side-chain amino groups 
of lysines, thiol groups of cysteine side chains or the side-chain carboxylic acid groups of 
aspartic and glutamic acid residues. Owing to the abundance of lysine residues in 
proteins, cross-linkers targeting the former increase the chance of achieving successful 
cross-links (Rappsilber. 2011).  The distance created between two interacting residues of 
the cross-linker is determined by the length of the spacer-arm of the cross-linker. A 
typical cross-linking reaction results in three different species being created when 
analyzed by MS: type 0, type 1, and type 2 (Fig. 1.3). Types 0 are peptides linked to 
cross-linkers with a hydrolyzed, unreactive group at the other end (Schilling et al. 2003); 
in fragmentation spectra, these manifest in the same manner as peptides containing a 
modified amino acid (Schilling et al. 2003). Type 1 relate to peptides containing an 
internal cross-link on a single peptide chain; like type 0, these carry little information. 
Type 2, which correspond to cross-linking between two independent peptide chains, are  
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Figure 1.3 Products generated from a cross-linking reaction followed by proteolytic digestion. 
Type 2 cross-links (inter cross-links) are the cross-links most desired during protein-protein 
interaction experiments. (Figure taken from Leitner et al. 2010). 
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the most informative; if the peptides belong to different proteins they provide information 
about protein-protein interactions. If the peptides belong to the same protein, they either 
provide information about the folded structure of the protein or about the spatial 
arrangement of the protein in homo-oligomeric complexes. 
 
CXMS has provided a platform for the elucidation of macromolecular interactions, 
including the spatial rearrangement of protein complexes (Maiolica et al.  2007) and 
protein-protein interactions within larger macromolecular assemblies (Sharon et al. 2006). 
Cross-link analysis can provide positional information on flexible, transient and modular 
higher-order multi-protein complexes, by mapping regions of partial proximity (Chen et 
al.  2010). It provides precise information concerning the interactions between subunits, 
thereby enabling improved modeling and docking of subunits (Stengel et al. 2012). 
Advances in cross-linked data analysis and identification has been improved by database 
searches that identify cross-linked sites in a manner similar to that of protein modification 
sites (Maiolica et al. 2007). Cross-linking data complements X-ray and NMR analysis, as 
shown by Maiolica et al. (2007), in which the spatial organization of a 180 kDa Ndc80 
complex was determined. Chen and co-workers (2010) successfully investigated the 
structure of the RNA polymerase II (Pol II) transcription initiation complex, using cross-
linking MS. They were able to extend the Pol II structure to a 15-subunit, 670 kDa 
complex of Pol II with the initiation factor TFIIF at peptide resolution (Chen et al. 2010).  
 
During the MS analysis, the cross-linked peptide first needs to be identified. Mass and 
fragmentation spectra are first acquired. The fragmentation spectrum reveals the exact or 
approximate sites of linkage, made possible by the fact that peptides normally follow 
specific fragmentation rules, breaking predominantly along the backbone at the peptide 
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bond. Fragment ions for linear peptides are considered to arise from cleavages at three 
positions of the repeating amide linkages: Cα – CO (a, x type) and CO – NH (b, y-type) 
and NH – Cα, with these cleavages being either heterolytic or hemolytic, and may also 
involve the transfer of one or more hydrogens with the charge retention at the N- (a, b, c-
type) or C-terminus (x, y, z-type) (Schilling et al. 2003). The most common 
fragmentation method, Collision Induced Dissociation (CID), gives rise to two main 
fragment types, N-terminal ‘b-ions’ and C-terminal ‘y-ions’ (Fig. 1.4), which are seen 
under low-energy conditions.  
 
The peaks obtained in fragmentation spectra are labeled using these letters, in conjunction 
with a subscript for the number of residues contained in the fragment, and a superscript 
for the number and type (positive or negative) of charges of the ion (Rappsilber. 2011). If 
a set of fragments is observed that fall upstream and downstream of the cross-linked 
residues, the exact position of the cross-linking site can be determined (Rappsilber. 2011). 
A benchmark study for CXMS was established in 2010 by Chen et al., in which the cross-
linked complex of PolII initiation factor TFIIF was investigated. During the analysis of 
the cross-link and fragmentation data, a spectrum (Fig. 1.5) shows that the fragments 
determining the linkage sites are red b1 and y13 and green y4/y5 and b4/b5 (Chen et al. 
2010).  
 
1.5 The RBBP6 protein family 
Retinoblastoma Binding Protein-6 (RBBP6), also known as p53-Associated Cellular 
Protein Testes-derived (PACT) and Proliferation Potential-Related Protein (P2P-R), is a 
250 kDa multi-domain nuclear protein, which interacts with the tumor suppressor proteins 
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pRb and p53 (Sakai et al. 1995, Simons et al. 1997, Witte and Scott 1997). The protein 
has been demonstrated  
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4 Ion fragments most commonly seen under low-energy conditions. CID, a low-energy 
fragmentation method, gives rise to N-terminal ‘b-ions’ or C-terminal ‘y-ions.’ Figure taken from 
Schilling et al. (2003). 
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Figure 1.5 Fragmentation spectrum of a cross-linked peptide. The fragment peaks are annotated 
according to the peptide that fragmented and the naming convention for peptides. The spectrum 
features fragments of both cross-linked peptides, thereby leading to confident and unambiguous 
identification of both peptides. Figure taken from Rappsilber (2011).  
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to be involved in pre-mRNA processing and splicing in yeast (Vo et al. 2001), as well as 
the regulation of apoptosis and cell cycle progression (Li et al. 2007). At least three major 
transcripts are produced from the RBBP6 gene, by a combination of alternative splicing 
and alternative polyadenylation in humans. These transcripts encode proteins of 1792, 
1758 and 118 amino acids respectively, which have been designated isoforms 1, 2 and 3 
(Genbank: NP_008841, Genbank: NP_061173, Genbank: NP_116015). The domain 
organization of RBBP6 proteins from different eukaryotic organisms is shown in Fig. 1.6. 
The gene is found in all eukaryotic genomes analyzed to date as a single copy.  
 
All RBBP6 homologues have an N-terminal ubiquitin-like domain, called the DWNN 
domain, followed by a CCHC zinc finger and a RING finger. In humans, the protein 
contains additional domains, including a proline rich domain (residues 337–349), SR 
domain (residues 679–773), as well as the pRb (964-1120) and p53 binding domains 
(residues 1142-1727) (Fig.1.6) (Pugh et al. 2006). In humans the DWNN domain is also 
independently expressed as a single domain protein, consisting of the DWNN domain and 
a long, unstructured C-terminal tail. In addition to these domains, RBBP6 contains 
extensive regions that are predicted to be intrinsically disordered.  
 
 
RBBP6 has been implicated in mRNA processing (Vo et al. 2001), cell cycle control and 
apoptosis (Gao and Scott. 2003).  Similarities between the RING-finger-like domain of 
RBBP6 and members of the U-box family, combined with its association with heat shock 
proteins, has led to the proposal that RBBP6 plays a role in chaperone-mediated 
ubiquitination of unfolded protein substrates (Kappo et al. 2012). It has been 
demonstrated in mice that knocking down RBBP6 leads to early embryonic lethality (Li 
et al. 2007). This would suggest that RBBP6 is important for cell growth and embryonic 
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development (Li et al. 2007). The Saccharomyces cerevisiae RBBP6 orthologue, Mpe1 
(mutant PCFII extrogenic suppressor 1 protein), has 441 amino acids and a molecular 
weight of 49.5 kDa. Mpe1p is essential for cell viability and has been demonstrated to 
interact with the PCF11 protein, which encodes a subunit of cleavage factor 1 (CF1) (Vo 
et al. 2001). CF1 is responsible for the specific cleavage and polyadenylation of pre-
mRNA. This gene is shorter than its human homologue and only contains the three 
conserved domains, namely the DWNN, zinc finger and RING domains. Vo et al. (2001) 
demonstrated that neutralization of Mpe1p by anti-Mpe1p antibodies completely inhibits 
polyadenylation of mRNA transcripts. In vitro studies conducted by Vo et al. (2001) 
demonstrated that Mpe1p is an integral subunit of the CPF (Cleavage and Polyadenylation 
Factor) although it is not essential for the overall stability of the CPF. In S. cerevisiae two 
complexes, CF1 (Cleavage Factor 1) and CPF, as well as the poly (A)-binding protein 
(PabIp), are responsible for the specific cleavage and polyadenylation of pre-mRNA (Vo 
et al. 2001). 
 
1.6 RING finger domains 
The RING (Really Interesting New Gene) finger domain is one of the most common zinc 
binding, cysteine-rich motifs and is a hallmark of E3 ubiquitin ligases. The motif consists 
of the general consensus sequence Cys-X (2)-Cys-X (9-39)-Cys-X (1-3)-His-X (2-3)-Cys-
X (2)-Cys-X (4-48)-Cys-X (2)-Cys, where X can be any amino acid. Fig. 1.7 is a 
diagrammatic representation of the structure of RING finger domains. An analysis of 
these structures revealed that all RING finger domains adopt a similar fold, but there are 
still significant differences present (Dominguez. 2004). 
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Figure 1.6 Domain organization of the RBBP6 protein family. All eukaryotic genomes contain a 
single gene containing the DWNN domain, zinc knuckle and RING finger domains, although in 
higher eukaryotes the gene contains additional C-terminal extensions. A short form containing 
only the DWNN domain is also found in higher eukaryotes, where it is expressed as an 
independent protein. (Taken from Pugh et al. 2006).  
 
 
 
 
 
 
Figure 1.7 Schematic representation of a RING finger domain indicating the ‘cross-brace’ 
topology for zinc ion coordination (Figure taken from Chasapis et al. 2009). 
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The overall structure of RING finger domains are characterized by a βαβ fold, but the 
presence, number, and exact positions of β-strands differ among these domain structures. 
RING fingers all share the same basic fold consisting of two large loops, each stabilized 
by a single zinc ion, lying parallel to an α-helix and together packing against a short 3-
stranded β-sheet (Kappo et al. 2012). A cluster of hydrophobic residues has been shown 
to be essential in maintaining ternary structures of all RING fingers (Dominguez et al. 
2004, Hanzawa et al. 2001). However, the main differences observed among the nine 
structures relate to the presence and length of their secondary structural elements. RING 
domains have been classified into different subclasses based on the variation of these 
secondary structure elements, as well as Zn
2+
 coordination. These are described in detail 
in the following section. 
 
1.6.1 Classification of RING finger domains 
RING finger domains can be divided into four subclasses: C3HC4, C3HHC3, C2H2C4, and 
C4C4 (Dominguez et al. 2004). Classification of these domains is based on Zn
2+
 ion 
coordination, sequence homology, and the presence and length of secondary structural 
elements. C3HC4, the classical RING domain, is the most common subclass of RING 
domains. The secondary structure of C3HC4 is composed of a three-stranded anti-parallel 
β-sheet packed against a central α-helix, thus adopting a ββαβ global fold (Kellenberger et 
al. 2005). The structure of the C3HC4 RING domain was first reported by Barlow and co-
workers in which they used 2D proton nuclear magnetic spectroscopy to determine the 
structure of the RING finger from the immediate-early EHV-1 protein (IEEHV) (Barlow 
et al. 1994). This structure was confirmed by Kellenberger and co-workers in which the 
structure of the RING finger from MAT1 was determined (Kellenberger et al. 2005),. The 
second largest subclass, C3HHC3, is also known as RING-H2. C3HHC3 differs from 
 
 
 
 
 
 24 
C3HC4 in that it contains a histidine residue at position 5 instead of a cysteine (as in 
C3HC4) (Katoh et al. 2003). Katoh and co-workers illustrated the structure of this subclass 
using EL5, a protein that is structurally related to the proteins of the A. thaliana ATL 
family (Katoh et al. 2003). 
 
Using NMR titration experiments, they showed that amino acids Val136, Cys137, 
Leu138, Val162, Trp135 and Leu174 form a highly conserved hydrophobic core, which is 
critical for hydrophobic interaction with an E2 enzyme, thus confirming the role of this 
domain in ubiquitination (Katoh et al. 2003). 
 
The third subclass of the RING domain is that of the C2H2C4 RING motif. This motif is 
found in the E3 ligase MDM2, which regulates the ubiquitination and degradation relating 
to the concentration, activity, and stability of p53 (Kostic et al. 2006). The first structure 
of a member of the C4C4 subclass was that of the CNOT4 RING domain, which was 
elucidated using NMR spectroscopy. Hanzawa and co-workers (Hanzawa et al. 2001) 
illustrated that this domain is composed of three loops and an α-helix between loops 2 and 
3, with no regular β-sheet. Using NMR Kellenberger and co-authors showed that the 
RING finger structure of p44 was the same as that of CNOT4, also adopting the C4C4 
structure (Kellenberger et al. 2005). The RING domains of CNOT4 and p44 are involved 
in transcriptional regulation.  The RING finger domain from RBBP6 has also been shown 
to belong to the C4C4 subclass, although the secondary structure bears little resemblance 
to that of CNOT4 (Kappo et al. 2012). 
 
The U-box domain is structurally related to RING fingers but lacks the hallmark metal-
coordinating residues of the latter (Aravind and Koonin. 2000). It is a peptide chain of 
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~70 amino acids that was first identified in the yeast protein UFD2 (ubiquitin fusion 
degradation protein 2), and subsequently demonstrated by Pringa and co-workers to be 
present in all eukaryotes (Pringa et al. 2000). U-boxes lack zinc-coordinating residues 
(Houben et al. 2005) but instead, hydrophobic residues stabilized by salt bridges and 
hydrogen bonds replace the zinc coordinating residues, thus stabilizing the U-box 
(Andersen et al. 2004). U-boxes function the same way as RING fingers, by acting as E3 
ubiquitin ligases and mediating ubiquitination. U-boxes occur less abundantly than RING 
fingers, as evident by the fact that only two U-box proteins occur in the S. cerevisiae 
genome (Ohi et al. 2003).  
1.6.2 RING fingers and ubiquitination 
Ubiquitination refers to post-translational modification of proteins by covalent attachment 
of one or more ubiquitin monomers (Fig. 1.8). Ubiquitin (Ub) is a 76 residue protein that 
is highly conserved from humans to fungi. Ubiquitination is achieved by the formation of 
an isopeptide bond between the C-terminal glycine residue of ubiquitin and the ε-amino 
group of a lysine residue from the accepting protein (Deriziotis and Tabrizi. 2008). This 
process is able to affect the localization, activity, structure and interaction partners of 
target proteins (Woelk et al. 2007). Once cleaved from its precursor polypeptide, Ub is 
subjected to an enzymatic reaction cascade involving Ub-activating (E1), Ub-conjugating 
(E2) and Ub-ligating (E3) enzymes (Kirkin. 2007). Ub can be attached as a monomer or 
as isopeptide-linked polymers (polyubiquitin chains) (Woelk et al. 2007). 
Polyubiquitination is accomplished through seven lysine residues on Ub that can serve as 
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Figure 1.8. The ubiquitination pathway. A hierarchical set of three types of enzyme is required for 
substrate ubiquitination: ubiquitin-activating (E1), ubiquitin-conjugating (E2) and ubiquitin-
protein ligase (E3) enzymes. (Figure taken from Woelk et al. 2007).  
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adaptors for the attachment of other Ub molecules (Woelk et al. 2007). An assembly of a 
chain of at least four ubiquitin molecules linked together via their Lys48 residue marks 
cellular proteins for degradation by the 26S proteasome, whereas polyubiquitination 
chains linked together via Lys63 serve as non-proteolytic signals in intracellular 
trafficking, DNA repair (Hicke et al. 2005) and signal transduction (Deshaies and 
Jaozeiro. 2009).  According to Kerscher and co-authors, most substrates are modified by 
multiubiquitin chains in which multiple ubiquitin molecules are linked via isopeptide 
bonds (Kerscher et al. 2006).  
  
Ubiquitination controls a number of fundamental cellular functions. These include 
apoptosis, antigen processing, DNA repair, intracellular protein trafficking, metabolism, 
quality control in the endoplasmic reticulum, signal transduction and stress responses 
(Deriziotis. 2008, Kerscher. 2006). Woelk and co-workers state that the activity of the 
ubiquitination system needs to be regulated as ubiquitination is often induced by 
extracellular stimuli and substrates are not constitutively recognized Woelk et al. 2007). 
Regulation of ubiquitination is often dependent on protein phosphorylation (Gao and 
Karin. 2005).  RING-based E3s are specified by over 600 human genes, and have been 
linked to the control of many cellular processes and to multiple human diseases (Deshaies 
and Joazeiro. 2009).  
 
1.6.3 Zinc ion coordination in RING fingers 
Zinc (Zn
2+
), the second most abundant transition metal in the human body, is critical for 
nucleic acid synthesis and consequently for cell division (Ramalho et al. 2009). It plays a 
central role in regulating cellular metabolism and is an essential cofactor of regulatory 
proteins, including proteins involved in apoptosis, DNA repair and proteins that control 
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gene expression (Ramalho et al.  2009). Zinc-binding proteins form a large group of 
metalloproteins in eukaryotic cells with a wide range of functions (Houben et al. 2005). 
The binding of zinc stabilizes the folded conformations of domains so that they may 
facilitate interactions between the proteins and other macromolecules such as DNA (Berg 
& Shi. 1996).  
  
Zinc is recognized for its structural role in maintaining the structural configuration of 
proteins. RING fingers, zinc fingers, and tumor suppressors like p53, are examples of 
proteins in which zinc plays a structural role. The identification of zinc-binding motifs in 
DNA-binding proteins has shown that zinc is used more for its structural purposes than 
for its catalytic roles (Houben et al. 2005). Proteins in which zinc plays a structural role 
may adopt tetrahedral, pentahedral or octahedral zinc coordination schemes (Dudev and 
Lim. 2003). Tetrahedral coordination is the most stable and seems to be the most favored 
as zinc is buried away from the solvent thereby neutralizing the positive charges on it. 
Earlier work by Kamura and co-workers showed that Rbx1 (a subunit of the SCF 
ubiquitin ligase) requires zinc for proper folding and ligase activity both in vitro and in 
vivo (Kimura et al. 1999). Not all RING domains exhibit intrinsic activity, as seen with 
BARD1 (Hashizume et al. 2001) and MDMX (Linares et al. 2003), which require an 
interaction with another RING domain (BRCA1 and MDM2 respectively), in which the 
formation of a heterodimer greatly stimulates E3 activity (Deshaies and Jaozeiro. 2009).  
 
1.6.4 The RBBP6 RING finger domain 
The RING finger domain of human RBBP6 is able to ubiquitinate YB-1, leading to its 
degradation in the proteasome (Chibi et al. 2008). YB-1 is a member of the cold-shock 
family of proteins which plays an important role in the maturation of mRNA transcripts. 
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It also functions as a transcription factor, transducing expression of a range of pro-
survival and pro-tumourigenic proteins (Lasham, A., Print, C. G., Woolley, A. G., Dunn, 
S. E. & Braithwaite, A. W. YB-1: oncoprotein, prognostic marker and therapeutic target? 
Biochemical Journal 449, 11-23 (2013)). The RING domain of human RBBP6 includes 
eight cysteine residues that coordinate two Zn
2+
 ions in a ‘cross-brace’ manner, in which 
the first and third cysteine pairs (Cys
259
, Cys
262
, Cys
281
, Cys
283
) coordinate the first Zn
2+
 
ion, while the second and fourth pairs (Cys
274
, Cys
275
, Cys
296
, Cys
299
) coordinate the 
second Zn
2+
 ion (Kappo et al. 2012). It therefore can be classified as a C4C4 RING finger 
(Kappo et al.  2012). Kappo and coworkers showed furthermore that the isolated RING 
homodimerises in solution along the same interface identified in many other RING 
fingers and U-boxes.   
 
Vo and co-workers identified Mpe1, the S. cerevisiae orthologue of human RBBP6, using 
genetic methods based on its essential role in mRNA processing (Vo et al. 2001). They 
drew attention to the RING domain as a cysteine-rich displaying some of the 
characteristics of a RING finger (Vo et al. 2001). Comparison of the human and yeast 
RBBP6 protein sequences indicates that the yeast homologue has lost three of the four 
residues coordinating one of the two zinc ions, suggesting that it may bind only one zinc 
ion (Fig. 1.9) (Kappo et al. 2012).  
 
The Aspergillus niger orthologue, when aligned to the Homo sapiens RING finger, shows 
an aspartic acid replacing a cysteine in the 1
st
 zinc ion binding pocket (Fig. 1.9). It may 
therefore, like its S. cerevisiae counterpart, bind one zinc ion or, like its human RING 
counterpart, bind two. 
 
 
 
 
 
 
 30 
 
 
Figure 1.9. Cross-brace configuration for Zn2+ binding.  Sequence analysis of RING finger 
domains from RBBP6 homologs reveals that HsRING finger binds 2 Zn2+ions, in which the 1st 
and 3rd pair of cysteine residues (red arrows) bind one Zn2+ and the 2nd and 4th pairs (black arrows) 
the other. The alignment reveals a disruption of the first pair of zinc binding site (red arrows) in 
the AnRING and ScRING homologs. The alignment reveals that some of the residues coordinating 
the first Zn2+ ion (red arrows) are missing from A. niger and S. cerevisiae, raising the possibility 
that both of these orthologues may bind only one Zn2+. 
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1.7 Objectives of this MSc project 
The aim of this research was to provide structural and functional insights into the function 
of the RBBP6 protein using mass spectrometry. More specifically, it aims to i) use non-
denaturing mass spectrometry to investigate protein-metal ion coordination in RING 
finger domains from the S. cerevisiae and A. niger members of the RBBP6 family using 
non-denaturing ESI-MS and ii) use cross-linking mass spectrometry to investigate 
previously-reported interactions of RBBP6 with Heat shock protein 70 (Hsp 70) and 
Mouse Double Minute 2 (MDM2). 
 
To investigate the zinc binding, expression constructs for both proteins first had to be 
generated, and then the proteins expressed in E. coli and purified to homogeneity. Since 
mass spectrometry under non-denaturing conditions had not previously been carried out 
successfully in South Africa, the technique first needed to be optimized with the 
assistance of the operators of instruments at Stellenbosch and Tygerberg. 
 
For the cross-linking analysis, samples of the putative interacting proteins needed to be 
generated as for aim i). Affinity pull-down and immunoprecipitation assays then needed 
to be used to confirm the interactions between the domains prior to cross-linking and 
analysis using tryptic digest-based mass spectrometry. 
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Chapter 2: Materials and Methods 
 
2.1 General Stock solutions and buffer preparation 
Ammonium Persulphate: A 10 % stock solution was prepared in deionised water. The 
solution was stored at 4 °C. 
Ampicillin: A 100 mg/ml stock solution was prepared in deionised water. The solution 
was filter-sterilized using a 0.22 micron filter and stored at -20 °C. 
Chloramphenicol: A 34 mg/ml stock solution was prepared in ethanol. The solution was 
stored at 4 °C until needed.  
Coomassie Staining Solution: 0.25 g Coomassie Blue R-250, 40 % ethanol and 10 % 
acetic acid in 250 ml deionised water. 
Destaining Solution: 15 % (v/v) acetic acid.  
Ethidium Bromide: 10 mg/ml stock solution was prepared in water, and stored in the 
dark at 4 °C.  
Protein Extraction Buffer: 50 mM Tris, pH 8, 150 mM NaCl, 100 g/ml lysozyme, 10 
mM -mercaptoethanol, 0.5% Triton X-100, 20 μg/ml ZnSO4. 
GTE: 50 mM Glucose, 50 mM Tris-HCl and 10 mM EDTA, pH 8.0.  
IPTG: A 1 M stock solution was prepared in deionised water. The solution was filter-
sterilized, aliquoted and stored at -20 °C.  
Luria Agar: 10 g/l Tryptone powder, 5 g/l Yeast extract, 5 g/l NaCl and 14 g/l 
Bacteriological agar. 
Luria Broth: 10 g/l Tryptone powder, 5 g/l Yeast extract, 5 g/l NaCl and 2 g/l Glucose.  
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Minimal Media: 12.8 g/l Na2HPO4-7H2O, 3 g/l KH2PO4, 1 g/l NH4Cl and 0.5 g/l NaCl. 
The pH of this media was adjusted to 7.0 with NaOH and the solution was 
autoclaved. Immediately prior to use, the solution was supplemented with 2 ml of 
autoclaved 1 M MgSO4, 100 l of autoclaved 1 M CaCl2 and 10 ml of filter-
sterilized 20 % Glucose. The solution was stored at room temperature. For labeled 
minimal media 1g/liter 
15
N- labeled NH4Cl was added to the media. 
NMR Buffer: 100 mM Sodium phosphate buffer pH 6.0, 150 mM NaCl, 5 mM DTT and 
0.02 % sodium azide.  
Non-denaturing mass spectrometry buffer: 10 mM ammonium acetate, pH 6.0 
Phenol/Chloroform: 1 part Tris-saturated phenol and 1 part chloroform. The solutions 
were mixed together and used fresh. 
3C Protease Cleavage Buffer: 50 mM Tris-HCl pH 7.0 containing 150 mM NaCl, 1 mM 
DTT and 0.01 % Triton X-100. The buffer was prepared fresh immediately prior 
to use. 
Protein Elution Buffer: 20 mM Glutathione and 50 mM Tris-HCl pH 8.0.  
Protein Wash Buffer: 50 mM Tris, pH 8.0, 150 mM NaCl and 10 mM -
mercaptoethanol. 
2X SDS PAGE Sample Buffer: 4 % SDS, 0.125 M Tris-HCl pH 6.8, 15 % Glycerol and 
1 mg/ml Bromophenol Blue. The buffer was stored at room temperature and 100 
mM freshly prepared DTT was added immediately prior to use.  
10X SDS PAGE Electrophoresis Buffer: 30.2g Tris, 144.1 Glycine and 10 g SDS. The 
buffer was stored at room temperature and diluted 10-fold when needed. 
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Separating Buffer: 1.5 M Tris-HCl, adjusted to pH 8.8 with HCl. The buffer was stored 
at   4 °C. 
Stacking Buffer: 0.5 M Tris-HCl, adjusted to pH 6.8 with HCl. The buffer was stored at      
4 °C. 
 5X TBE: 54 g Tris, 27.5 g boric acid, 20 ml 0.5M EDTA, pH 8.0. 
Tfb1 Buffer: 30 mM Potassium acetate, 50 mM MnCl2, 0.1 M KCl, 6.7 mM CaCl2 and 
15 % Glycerol (v/v). 
 Tbf2 Buffer: 9 mM MOPS, 50 mM CaCl2, 10 mM KCl and 15 % Glycerol (v/v). 
 TYM Broth: 20 g/l Tryptone powder, 5 g/l Yeast extract, 3.5 g/l NaCl and 2 g/l MgCl2. 
 
2.2 Bacteria and yeast strains 
 
Bacteria 
1. E.coli MC1061 (Casadabhan and Cohen, 1980): F-, araD139, (ara leu) 7697, Δlacx74, 
galU-, galK-, hs-, hsm+, strA 
2. E.coli BL21 StarTM pLysS (DE3) (Stratagene): F- omp T hsdSB (rB-mB-) gal dcm 
rne131 (DE3) 
 
Yeast: 
Matchmaker Y2HGold yeast cells: MATa, trp1-901, leu2-3, 112, ura3-52, his3-200, 
gal4Δ, gal80Δ, LYS2 : : GAL1UAS–Gal1TATA–His3, GAL2UAS–Gal2TATA–Ade2 
URA3 : : MEL1UAS–Mel1TATA AUR1-C MEL1 2.1  
Yeast cells were a kind gift from Dr. Craig Kinnear, Stellenbosch University, Faculty of 
Health Sciences, Tygerberg. 
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2.3 Antibodies used  
 Anti-MDM2: mouse monoclonal 4B11, raised against  residues 383-491 of human 
MDM2 (Merck, Darmstadt, Germany) 
 Anti-RBBP6-RING: rabbit polyclonal custom raised against residues 249-335 of 
human RBBP6 (laboratory of Prof Dirk Bellstedt, Department of Biochemistry, 
University of Stellenbosch). 
 Anti-RBBP6-DWNN: mouse monoclonal custom raised against residues 1-81 of 
human RBBP6, (European Molecular Biology Laboratory, Monterotondo-Scalo, Italy) 
 Anti-Hsp70: mouse monoclonal 3A3 (Santa Cruz Biotechnology, Inc., Santa Cruz, 
CA, USA) 
 
2.4 Preparation of yeast genomic DNA 
A single medium-sized S. cerevisiae colony was resuspended in 30 l of 0.2 % SDS in a 
microfuge tube. The tube was vortexed for 15 seconds and thereafter placed in a 90 C 
heating block for 4 minutes. The tube was then centrifuged at 14000 rpm for 1 minute and 
the supernatant transferred to a new tube. The supernatant, containing the genomic DNA 
was then used as a template for the subsequent PCR reaction.  
 
2.5 PCR amplification of DNA 
PCR amplifications were carried out in reactions containing 1x PCR reaction buffer, 1.5 
mM MgCl2, 10 pmol forward and reverse primers, 0.2 mM dNTPs, and 0.25 U Taq 
polymerase. 1 l of yeast genomic DNA was used as a template for the PCR reaction. The 
final volume was made up to 25 l with sterile autoclaved water. The PCR reaction tubes 
were briefly centrifuged and the reaction mixture was cycled through the following 
parameters: 
 
 
 
 
 
 36 
 
94 
o
C for 2 minutes (Initial denaturation) 
92 
o
C for 1 min (Denaturation) 
60 
o
C for 1 min (Annealing) 
72 
o
C for 30 seconds (Extension) 
72 
o
C for 5 min (Final extension) 
The PCR reaction products were then analysed by electrophoresis on 1% agarose gels. 
 
2.6 Double restriction digestion of genomic DNA and pGEX-6P-2vector 
Double restriction digests of PCR products and plasmids were carried out as follows: 
 
Table 2.1 Restriction digestion of the RING PCR product and pGEX-6P-2 vector. 
 
 
The reagents were mixed in a 1.5 ml microfuge tube and incubated at 37 C for 1.5 hours. 
The samples were analyzed by electrophoresis on a 1% agarose gel. 
 
2.7 Agarose gel electrophoresis of DNA  
 
DNA was analyzed by electrophoresis on 1% agarose gels.  Gels were prepared by adding 
the required volume of 1 X TBE to the appropriate mass of electrophoresis grade agarose. 
The agarose was boiled and cooled to 55 C followed by the addition of GR Green to a 
final concentration of 0.5 µg/ml and poured onto a gel-casting tray. 0.5 l of 6x loading 
S. cerevisiae A. niger pGEX-6p-2
DNA (1μg) 20μl 15μl 11
10x buffer 10μl 10μl 10μl
BamHI 1μl 1μl 1μl
XhoI 1μl 1μl 1μl
dH20 68μl 73μl 77μl
Species/ vector
Reagent
30 cycles 
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buffer was mixed with 5-20 µl of the DNA and loaded onto the gel. The marker was 
loaded in the first lane to show the sizes of the bands. The DNA was visualized by placing 
the gel under UV light.  
 
2.8 Cohesive end ligation 
Ligation reactions were set up as shown in Table 2.2. The ligation reactions were 
incubated overnight at 4 C. 10 l of the ligation was used to transform E. coli MC1061 
competent cells. Transformed cells were plated on LB agar plates containing 100 µg/ml 
ampicillin and grown overnight at 37 C. 
 
Several isolated colonies were picked and screened for inserts by double restriction 
digests as described in Section 2.6. The remaining cell suspension from positive clones 
were used to inoculate 10 ml of LB broth containing 100 µg/ml ampicillin and grown 
overnight at 37 C. The cells were harvested and plasmid DNA isolated using a Genejet 
plasmid isolation kit (Fermentas). Constructs were then validated using colony PCR, as 
well as double restriction digest. 
 
Table 2.2 Ligation reactions for cloning DNA fragments into pGEX-6P-2expression vector 
 
 
 
Control Experimental Control Experimental 
Vector (pGEX-6P-2) 4.5µl 4.5 µl 5µl 5 µl
PCR products 0 µl 2 µl 0 µl 2.6 µl
10 X ligation buffer 2 µl 2 µl 2 µl 2 µl
T4 DNA Ligase 1 µl 1 µl 1 µl 1 µl
dH2O 13.5 µl 11.5 µl 12µl 9.4µl
Total volume 20 µl 20 µl 20 µl 20 µl
S. cerevisiae A. niger
Species
Reagent
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2.9 Colony PCR assay 
Colony PCR was used to screen transformed colonies for the presence of the S. cerevisiae 
RING insert. Following transformation, single colonies were picked and resuspended in 
20 l of distilled water. 1 l of each suspension was added to the PCR reaction and the 
reaction carried out as described in Section 2.5. Cycling parameters were similar to the 
PCR reaction carried out earlier with the exception of the denaturation temperature 
changing to 94 C, the annealing temperature to 58 C, and the extension time to 45 
seconds.  
 
The sequence identity of positive clones was confirmed by DNA sequencing, carried out 
at Inqaba Biotechnical Industries (Pty) Ltd. Results were then compared to the expected  
sequences using the BLAST 2 alignment tool: 
(http://www.ncbi.nlm.nih.gov/BLAST/bl2seq/wblast2). 
 
2.10 Transformation of plasmid DNA into competent cells 
Frozen E. coli MC1061 and BL21 (DE3) pLysS competent cells were thawed on ice. 10 
l of the ligation mixture was added to 100 l of competent cells. The tube was then 
gently finger-tapped and left on ice for 30 minutes. Cells were heat shocked at 37 C for 5 
minutes and then placed back on ice for 5 minutes. 900 l of Luria-Bertani broth (no 
antibiotics) was then added to the tube, which was thereafter incubated for 1 hour at 37 
C. 100 l of the transformation culture was then spread on a Luria-Bertani agar plate 
containing 100 g/ml ampicillin and incubated overnight at 37C. 
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2.11 Large-scale expression of recombinant protein 
 
Single colonies of E. coli BL21 (DE) pLysS cells transformed with expression plasmids 
were inoculated into 6 ml LB containing 100 µg/ml ampicillin and 34 µg/ml 
chloramphenicol and incubated at 37 C with shaking. After 4 hours, the culture was used 
to inoculate 200 ml of enriched media (LB) containing 100 µg/ml ampicillin and 34 
µg/ml chloramphenicol, and grown overnight at 37 C. Three hours later the cultures were 
scaled-up to 2000 ml by addition of media containing the same concentration of 
ampicillin and incubated at 37 C with shaking until the OD550 reached 0.4 - 0.6.  
 
One hour prior to induction, 100 M ZnSO4 was added for proper folding of the protein. 
Induction was carried out at 25 C for 16 hours by addition of IPTG to a final 
concentration of 1 mM for the S. cerevisiae RING finger, and 0.5 mM for the A. niger and 
H. sapiens RING fingers respectively. Following induction the bacterial cells were 
harvested by centrifugation at 6000 rpm for 10 minutes at 4 C. The pellets were 
resuspended in 25 ml extraction buffer containing protease inhibitor cocktail tablets 
(Roche Applied Science, Penzberg, Germany) and stored at -20 C until needed.  
 
Cell lysis was achieved by sonication, which comprised of 5 cycles: 30 seconds pulse, 30 
seconds on ice. This was followed by centrifugation at 4 C at 4300 g, after which the 
supernatant was held at 4 C until further purification was performed. 
 
2.12 Glutathione affinity purification of GST-fusion proteins 
Glutathione agarose beads (SIGMA, Missouri, USA) were swollen overnight at 4 C in 
distilled water according to the manufacturer’s instructions.  
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The beads were thereafter transferred to a 50 ml chromatography column (Bio-rad, 
Hercules, California) column and washed thoroughly with PBS buffer containing DTT to 
remove traces of lactose present in the lyophilized beads. For long-term storage the beads 
were stored in 1 M NaCl at 4 C. Prior to purification of the GST fusion protein, the 
column was equilibrated with 2 column volumes of wash buffer (1x PBS with 1 mM 
DTT). The bacterial lysate was applied to the column and the flow-through collected. The 
column was washed twice with 10 ml wash buffer and the flow-through collected. The 
retained fusion protein was eluted with 50 ml elution buffer (20 mM Glutathione in 1x 
PBS with 1 mM DTT). The beads were thereafter stored in 10 ml 2 M NaCl. 
 
2.13 Cleavage of the GST-fusion proteins using 3C protease 
3C protease from human rhinovirus (HRV 3C) was recombinantly expressed as a GST-
fusion protein and stored at -20 C. The purified GST-RING fusion proteins were 
transferred to a SnakeSkin Pleated Dialysis Tubing (MWCO 3500Da) (Thermo 
Scientific, Waltham, Massachusetts, USA) and 100 l of 3C protease added. The dialysis 
bag was then placed in 5000 ml cleavage buffer and incubated overnight at 4 C with 
stirring.  
 
Following cleavage, the target protein was separated from GST in a second round of 
glutathione affinity purification, with the target protein remaining in the flow through and 
GST and 3C protease being retained on the column. 
 
2.14 Size exclusion chromatography 
RING finger domains were purified to homogeneity using size exclusion 
chromatography, achieved using an ÄKTA FPLC chromatography system (GE 
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Healthcare, Little Chalfont, UK). A 120 ml Superdex 75 16/600 column (Amersham 
Biosciences, Pittsburgh, USA) was equilibrated with 1 column volume of 1x PBS with 1 
mM DTT before concentrated protein samples were loaded onto the column. Eluted 
proteins were collected in 2 ml fractions. 
 
For cross-linking experiments, interacting proteins were allowed to incubate for at least 2 
hours in an equi-molar ratio before being subjected to size exclusion chromatography in 
order to generate a complex between the two interacting proteins.  
2.15 SDS-PAGE gel electrophoresis 
Proteins were analyzed by electrophoresis on 16% polyacrylamide gels using Laemmli’s 
method (Laemmli, 1970). The separating gel was prepared from 4 ml 40% acrylamide: 
bis-acrylamide stock, 2.63 ml separating buffer, 40 l 10 % ammonium persulphate, 105 
l 10% SDS, 7.5 l TEMED and the volume was made up to 10 ml using distilled water. 
The stacking gel was prepared from 0.5 ml 40% 37:5:1 polyacrylamide, 25 l 10% APS, 
50 l 10% SDS, 1.25 ml stacking buffer, 5 l TEMED and the volume was made up to 5 
ml using distilled water.  
 
Samples were mixed with equal volumes of 2x SDS sample buffer, incubated in a heating 
block at 95 C for 10 minutes and centrifuged for 2-3 minutes at 13300 rpm. The samples 
were then separated by electrophoresis at using a BioRad Mini-Protean system.  
 
Once the dye front had reached the end of the gel, the gel was removed from the caster 
and incubated in Coomassie staining solution for 15 minutes. Thereafter it was transferred 
into destaining solution and left to destain until the background was clear. 
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2.16 ESI-MS of RING finger domain proteins 
Pooled fractions of the 3 pure RING finger domain proteins were concentrated and buffer 
exchanged into 10 mM ammonium acetate using concentrators (Millipore, 3000 MWCO). 
Protein samples were then subjected to ESI-MS using a Waters API Q-TOF Ultima 
instrument (Stellenbosch University). Using the column attached to the MS the samples 
were introduced to the MS using 1% formic acid to obtain a denatured spectrum, after 
which samples, using 10 mM ammonium acetate were subjected to the MS. MS data were 
acquired in positive scan mode. 
 
2.17 Affinity pull-down assays 
GST and His pull-down assays were performed by expressing the GST/6His -tagged bait 
proteins in E. coli. E. coli cell lysates containing GST/His-tagged bait proteins were 
clarified by centrifugation and the total cellular protein concentration estimated by 
measuring the absorbance at 280 nm. Untagged purified prey proteins were prepared as 
described above. Aliquots of tagged bait proteins or GST only were mixed with the prey 
protein, 20 μl of a 20% glutathione agarose slurry and 500 μl Binding Buffer (50mM Tris, 
pH 8.0, 5% BSA, 20 μM ZnCl2, 200 mM NaCl, 20 mM β-mercaptoethanol, 0.5% Triton 
X-100) and were incubated for 1 hour at room temperature. Additional reactions were 
included from which the E. coli lysate was omitted completely to serve as negative 
controls. The beads were pelleted by centrifugation and washed 3 times with 500 μl of 
Binding Buffer, followed by 2 washes with 0.5 M NaCl.  
 
Finally the beads were resuspended in 30 μl of SDS sample buffer, boiled for 5 minutes at 
95 °C and loaded onto an SDS-PAGE gel. Prey proteins were immunodetected with the 
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appropriate antibodies. For immunoprecipitation antibodies were coupled to Affi-gel 
matrix (Biorad, Hercules, California) 
 
2.18 Chemical cross-linking 
Cross-linking involves the conversion of non-covalent interactions between proteins into 
covalent ones (Rappsilber. 2011). Interacting proteins under scrutiny retain these covalent 
bonds, even when subjected to denaturing conditions like SDS-PAGE. Purified 
recombinant proteins were cross-linked using Sulfo-MBS or BS
3
 (SIGMA, Missouri, 
USA), after which they were analyzed using SDS-PAGE. Bands of interest were excised, 
and subjected to MALDI-TOF MS to identify and localize regions of interaction. 
 
2.19 Immuno-detection of Proteins 
Protein samples were subjected to SDS-PAGE as described in Section 2.11.5. Thereafter 
proteins were transferred to nitrocellulose or PVDF membranes using 25 mM Tris, 0.2 M 
glycine and 20% methanol as transfer buffer. Following the transfer, the membranes were 
blocked with 5% milk in TBS-T (Tris buffered saline containing 0.1% Tween 20) and 
then incubated with the appropriate primary and secondary antibodies for 1 hour each. 
Following three 5-minute washes with TBS-T, the membranes were incubated with 
SuperSignalR West Pico chemiluminescent substrate solution (Pierce Biotechnology, 
Rockford, Illinois, USA), exposed to film and developed. 
 
2.20 Mass spectrometry 
Gel pieces were cut into smaller cubes and washed twice with water followed by 50% 
(v/v) acetonitrile for 10 min. The acetonitrile was replaced with 50 mM ammonium 
bicarbonate and incubated for 10 min, and repeated two more times. All the gel pieces 
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were then incubated in 100% acetonitrile until they turned white, after which the gel 
pieces were dried in vacuo. Proteins were reduced with 10 mM DTT for 1 h at 57 °C. This 
was followed by brief washing steps of ammonium bicarbonate followed by 50% 
acetonitrile before proteins were alkylated with 55 mM iodoacetamide for 1 h in the dark. 
Following alkylation the gel pieces were washed with ammonium bicarbonate for 10 min 
followed by 50% acetonitrile for 20 min, before being dried in vacuo. The gel pieces were 
digested with 20 μl of a 10 ng/μl trypsin solution at 370C overnight. The resulting 
peptides were extracted twice with 70% acetonitrile in 0.1% formic acid for 30 min, and 
then dried and stored at -20 °C. Dried peptides were dissolved in 5% acetonitrile in 0.1% 
formic acid and 10 μl injections were made for nano-LC chromatography. 
 
All experiments were performed on a Thermo Scientific EASY-nLC II connected to a 
LTQ Orbitrap Velos mass spectrometer (Thermo Scientific, Waltham, Massachusetts, 
USA) equipped with a nano-electropsray source. For liquid chromatography, separation 
was performed on a EASY - Column (2 cm, ID 100μm, 5 μm, C18) pre-column followed 
by a EASY - Column (10 cm, ID 75 μm, 3 μm, C18) column with a flow rate of 300 
nl/min.  
 
The gradient used was from 5-40 % B in 20 min, 40-80% B in 5 min and kept at 80% B 
for 10 min. Solvent A was 100% water in 0.1 % formic acid, and solvent B was 100 % 
acetonitrile in 0.1% formic acid.  
 
The mass spectrometer was operated in data-dependent mode to automatically switch 
between Orbitrap-MS and LTQ-MS/MS acquisition. Data were acquired using the 
Xcaliber software package. The precursor ion scan MS spectra (m/z 400 – 2000) were 
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acquired in the Orbitrap with resolution R = 60000 with the number of accumulated ions 
being 1 x 106. The 20 most intense ions were isolated and fragmented in linear ion trap 
(number of accumulated ions 1.5 x 104) using collision induced dissociation. The lock 
mass option (polydimethylcyclosiloxane; m/z 445.120025) enabled accurate mass 
measurement in both the MS and MS/MS modes. In data-dependent LC-MS/MS 
experiments, dynamic exclusion was used with 60 s exclusion duration. Mass 
spectrometry conditions were 1.5 kV, capillary temperature of 200 °C, with no sheath and 
auxiliary gas flow. The ion selection threshold was 500 counts for MS/MS and an 
activation Q-value of 0.25 and activation time of 10 ms were also applied for MS/MS. 
 
Thermo Proteome Discoverer 1.3 (Thermo Scientific, Waltham, Massachusetts, USA) 
were used to identify proteins via automated database searching (Mascot, Matrix Science, 
London, UK) of all tandem mass spectra against the in-house database provided by the 
host. Carbamidomethyl cysteine was set as fixed modification, and oxidized methionine, 
N-acetylation and deamidation (NQ) was used as variable modifications. The precursor 
mass tolerance was set to 10 ppm, and fragment mass tolerance set to 0.8 Da. Two missed 
tryptic cleavages were allowed.  
 
Proteins were considered positively identified when they were identified with at least 2 
tryptic peptides per proteins, a Mascot or Sequest score of more that p<0.05 as determined 
by Proteome Discoverer 1.3. Percolator was also used for validation of search results. In 
Percolator a decoy database was searched with a FDR (strict) of 0.02 and FDR (relaxed) 
of 0.05 with validation based on the q-value. 
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Chapter 3: Results - Protein-metal ion interactions 
 
3.1 Introduction 
The RING finger domain from human Retinoblastoma Binding Protein-6 (RBBP6) binds 
two Zn
2+
 ions in two zinc binding pockets (Kappo et al. 2012). Analysis of the sequences 
of orthologues from other eukaryotes reveal a number of cases in which zinc coordinating 
residues were missing, suggesting the possibility that these proteins might only bind one 
Zn
2+
. In Aspergillus niger, for example, one of the cysteine (C) residues making up zinc 
binding site 1 has been replaced by aspartic acid (D). In Saccharomyces cerevisiae three 
of the four zinc coordinating residues have been lost. In order to determine how many 
zinc ions were coordinated by the RING finger domains from A. niger and S. cerevisiae, 
these domains were cloned and expressed in E. coli and non-denaturing mass 
spectrometry used to determine the effective molecular weights of the proteins in 
solution. As a control the human orthologue was subjected to the same analysis, since it 
had previously been shown, using NMR, to bind two Zn
2+
 ions.  
 
3.2 Generation of GST-RING finger domain expression constructs 
Analysis of the genomic sequence of the S. cerevisiae orthologue of RBBP6 
(NM_001179625) showed that it contained no introns. We therefore decided to amplify it 
directly out of genomic DNA using a ‘colony PCR’-type approach. Yeast cells were a 
kind from Dr. Craig Kinnear, Stellenbosch University, Health Sciences, Tygerberg. 
Primers were designed incorporating a BamHI into the forward primer and an XhoI site 
into the reverse primer (Fig. 3.1), for cloning into the BamHI and XhoI sites of the 
pGEX-6P-2 expression vector respectively. Two stop codons, TAA and TGA, were 
included in the reverse primer (Fig 3.1). The ScRING was successfully amplified from yeast  
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Figure 3.1 (a) Primers designed for the amplification of S. cerevisiae included BamHI and XhoI 
restriction sites (bold) in the forward and reverse primers respectively, as well as two stop codons 
(underlined) immediately upstream of the XhoI site. (b) The A. niger sequence synthesized by 
Genscript Inc. was flanked by BamHI and XhoI sits. A single stop codon was added immediately 
upstream of the XhoI site. (c) The A. niger sequence was optimized by Genscript Inc. to increase 
the efficiency of expression in E. coli. Primers were synthesized by the DNA synthesis facility at 
the University of Cape Town.  
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Figure 3.2 Amplification and cloning of the RING finger domain from S. cerevisiae. a) ScRING 
amplified directly from genomic DNA yielded the expected product of 267 bp (lanes 2 and 4). 
Lanes 1 and 3 contained no template DNA. b) Following colony PCR the 267bp fragment 
corresponding to the ScRING validated the successful cloning of the gene into the pGEX-6P-2 
expression vector. Lanes 2, 3, 4, 7, 9, 10 correspond to positive clones. Lane 1 is the negative 
control for the PCR reaction as it contains no template DNA. 
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cells (Fig. 3.2.a) and cloned into the pGEX-6P-2 expression vector (Fig. 3.2.b), as confirmed by 
the amplified bands in Fig. 3.2 (b) , lanes 2-4, 7, 9 and 10.The AnRING finger 
(XP_001392158.1) was synthesized by Genscript Inc. (Piscataway, NJ, USA.) and 
received in a pUC57 vector. The sequence was codon optimized for expression of the 
protein in E. coli and incorporated a BamHI site at the N-terminus and an XhoI site at the 
C-terminus (Fig. 3.1 (b) and (c)). A single stop codon was incorporated immediately 
following the end of the gene. The pUC57 vector was digested with restriction enzymes 
BamHI and XhoI, releasing an insert of 252 bp as expected (Fig.3.3.a). The insert was 
successfully cloned into E. coli MC1061 competent cells, as confirmed by the presence of 
a fragment of the correct size in lane 5 of Fig. 3.3.b).  
 
Cell suspensions from positive clones were used to inoculate 10 ml of LB broth 
containing 100 µg/ml ampicillin and grown overnight at 37 C. Plasmid DNA was 
isolated from these overnight cultures using a Genejet plasmid isolation kit (Fermentas, 
Vilnius, Lithuania). 
 
Following the isolation of plasmid DNA from positive clones, 10 l of one of the positive 
clones were sent for sequencing at Inqaba Biotechnical Industries (Pty) Ltd. Sequences 
were analyzed as described in Sec. 2.5. Fig. 3.4 shows the sequences of the clones were in 
100 % agreement with the expected sequences. Cloned fragments were transformed into 
the E. coli BL21 (DE) pLysS expression strain of competent cells, and single colonies 
used to grow up proteins. 
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Figure 3.3 Sub-cloning of the RING finger domain from A. niger into pGEX-6P-2. a) A 252 bp 
fragment corresponding to the gene of interest was released when the pUC57-AnRING was 
digested with BamHI and XhoI. (b) The A. niger RING was successfully sub-cloned into pGEX-
6P-2, as confirmed by the presence of a 252 bp fragment, following digestion of plasmid DNA 
extracted from positive clones. Lanes 1, 3 and 5 represent positive clones.  
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Figure 3.4 Experimentally determined sequences (Sbjct) were in 100 % agreement with expected 
sequences (Query) for ScRING (a) and AnRING (b). Flanking sequences for restriction enzymes 
BamHI (GGATCC)) and XhoI (CTCGAG) are indicated in yellow. 
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3.3 Expression and purification of RING finger proteins 
Expressed, soluble proteins were then separated from insoluble proteins and cell debris by 
centrifugation at 16000 rpm for one hour. The pGEX-6P-2 expression vector used 
allowed for the expression of the proteins of interest as fusions with GST, allowing the 
purification of the proteins on a glutathione agarose column. Cell lysates, containing 
GST-fusion proteins, were passed through a prepared glutathione agarose column and 
GST-fusion proteins were retained on the column, and separated from unwanted E. coli 
proteins. Fusion proteins were eluted from the column following the addition of 20 mM 
reduced glutathione. Fig. 3.5 shows that the RING finger fusion proteins were all 
expressed at high levels and successfully purified using GST glutathione affinity 
chromatography. 
 
Fractions corresponding to the fusion proteins were then pooled together and placed in a 
SnakeSkin dialysis membrane in cleavage buffer, together with human rhinovirus 3C in 
order to (i) to cleave off the GST tag and (ii) remove the free glutathione from the sample. 
In a second round of GST affinity chromatography the cleaved sample was then re-loaded 
onto the glutathione-agarose column and cleaved GST and uncleaved fusion protein were 
retained on the column while the target protein remained in the flow-through (Fig. 3.6).  
 
Fractions containing RING proteins were loaded onto a size exclusion column to remove 
remaining GST and 3C protease (Fig.3.7). Finally RING domains were exchanged either 
into non-denaturing mass spectrometry buffer or NMR buffer. 
 
1D proton NMR spectra were acquired at 600 MHz to assess the state of foldedness of 
both samples. The high level of chemical shift dispersion of the spectra shown in Figs. 3.8 
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and 3.10 shows that the RING fingers from S. cerevisiae and A. niger were folded prior to 
MS. 
15
N-enriched samples of the S. cerevisiae domain were expressed in minimal media 
supplemented with 
15
N-ammonium chloride (Cambridge Isotope Laboratories, Andover 
MA, USA) and used to record 2D 
15
N-HSQC spectra. The spectra in Fig 3.9 are very well 
dispersed in both 
1
H and 
15
N dimensions and there is very little overlap, suggesting that 
this protein would be suitable for detailed structural analysis using triple-resonance NMR. 
Fig. 3.9 shows a superposition of spectra corresponding to the protein at 1x (black) and 
10x (red) dilution respectively; the lack of significant changes suggests that the protein is 
likely to be monomeric in solution. This can be contrasted with the human RING finger 
domain, which showed robust concentration-dependent chemical shift changes consisted 
with it forming a homodimer in solution.  
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Figure 3.5 Pure samples of GST-RING finger proteins from S. cerevisiae (a), A. niger (b) and H. 
sapiens (c) were eluted from the glutathione matrix following addition of 20 mM free glutathione. 
All three domains exhibit an apparent molecular weight of approximately 35 kDa, as expected, 
corresponding to 26 kDa (GST) plus 9 kDa (RING). 
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Figure 3.6 Successful cleavage with 3C protease and separation using glutathione affinity 
chromatography of GST-RING proteins from S. cerevisiae (a), A. niger (b) and H. sapiens (c). In 
each case the un-cleaved fusion can be seen in lane 1 and the cleaved sample in lane 2. Lane 3 and 
upward show varying degrees of successful separation of GST from the RING finger using a 
second round of glutathione affinity chromatography. 
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Figure 3.7 Size exclusion chromatogram and associated SDS-PAGE showing successful 
purification of the HsRING finger domain. With the exception of a small amount of overlap in 
lanes 3 and 4, the procedure successfully separated the cleaved GST from the target protein. 
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Figure 3.8 1D 1H spectrum of S. cerevisiae RING finger domain at pH 6.0, 25 °C recorded at 600 
MHz. The large chemical shift dispersion of resonances and sharp peaks exhibited by the protein 
is indicative of its foldedness.  This is confirmed by the appearance of resonances corresponding 
to amide protons (HN) in the region 9-11 ppm, α-protons (Hα) in the region 5-6 ppm, and methyl 
groups in the region 0-0.5 ppm. The sharpness of the peaks also indicate that the protein is 
monomeric.  
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Figure 3.9 15N-HSQC spectrum of a 10x diluted ScRING (red) superimposed over the 
concentrated sample (black). Spectra were recorded at pH 6.0, 25C at 600MHz. The absence of 
concentration-dependent chemical shift perturbations suggests that the domain is monomeric in 
solution. 
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Figure 3.10 1D 1H spectrum of the A. niger RING finger domain at pH 6.0, 25 °C, recorded at 600 
MHz. The high level of dispersion (some HN resonances in the region 9-10 ppm, some Hα in the 
region 5-6 ppm and methyl protons in the region 0-0.5 ppm) is an indication that the protein is 
folded. 
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3.4 ESI-MS of RING finger proteins 
3.4.1 Homo sapiens RING finger 
From its amino acid sequence, excluding bound zinc ions, the expected mass of the 
human RING finger was calculated to be 10 229 Da (http://web.expasy.org/protparam/). 
Under denaturing conditions (non-denaturing mass spectrometry buffer with the addition 
of 1 % formic acid) the mass of the protein was found to be 10 230 Da (Fig. 3.11.a). This 
is expected, since the denatured protein is not expected to be able to bind zinc ions.  
 
Under non-denaturing conditions (no formic acid) the mass of the most abundant species 
was 10 356 Da (Fig. 3.11.b); since the mass of a single Zn
2+
 ion is 65.4 Da, this 
corresponds to two Zn
2+
 bound to the protein, as expected on the basis of previous NMR 
studies (Kappo et al. 2012).  
 
Evidence of the HsRING finger occurring as a homodimer was also found (Fig. 3.11.c); 
the predominant species, at 20 711 Da, is consistent with the mass of two monomers, each  
binding two zinc ions (i.e. twice the mass of the monomer in (b)). Peaks corresponding to 
the homodimer binding a total of 3 (20 655 Da), 2 (20 588 Da), 1 (20 522 Da) and 0 (20 
458 Da) zinc ions can also be seen, none of which are present in denaturing conditions 
(a). The other peaks corresponding to additions of 22 Da correspond to Na-adducts, which 
result from incomplete de-salting of samples prior to ESI-MS.  
 
Non-denaturing ESI is therefore consistent with results previously obtained using solution 
state NMR: that the RING finger from H. sapiens RBBP6 binds two zinc ions and has a 
tendency to form homodimers. 
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Figure 3.11 Deconvoluted ESI-MS of Homo sapiens RING finger. a) The denaturing ESI spectrum 
reveals the protein to be 10230 Da when the protein is sprayed into the mass spectrometer using formic 
acid. b) The non-denaturing spectrum reveals the most abundant species to be the HsRING with 2 Zn2+ 
bound. c) The dimer with no Zn2+ bound, the dimer with 2 Zn2+ and the dimer binding 4 Zn2+. The other 
peaks are separated by approximately 22 Da and are likely to correspond to sodium adducts, which is a 
result of the protein being insufficiently desalted prior to MS.   
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3.4.2 Saccharomyces cerevisiae RING finger 
The amino acid sequence of the S. cerevisiae orthologue of RBBP6 showed that the first 
Zn
2+ 
binding pocket had been disrupted (Fig. 1.9), from which we hypothesized that it 
would bind only one Zn
2+ 
ion. The 1D 
1
H and 15N-HSQC spectra of the ScRING (Fig. 
3.8 and 3.9) revealed that the protein was folded prior to MS. The sharpness and well 
dispersed peaks of the 
1
H spectrum reveals that the ScRING is well folded (Fig 3.8) and 
the 
15
N-HSQC spectrum reveals that the protein remains monomeric in solution in a 
concentration dependent manner (Fig. 3.9). 
 
On the basis of the amino acid sequence the expected molecular weight of the protein 
excluding bound zinc was calculated to be 9 504 Da (http://web.expasy.org/protparam/). 
However, denaturing MS returned a mass of 9 610 Da (Fig.3.12.a), 106 Da larger than 
expected. 
 
Re-sequencing of the construct revealed two mutations, resulting in substitution of amino 
acid Valine (V) for Arginine (R), and Lysine for Phenylalanine, as is indicated with red 
dots in Fig. 1.9. Together these substitutions account for the observed mass increase of 
105 Da.  
 
Since neither of the mutated residues was expected to disrupt either of the two zinc 
binding sites, it was considered unlikely that the zinc binding properties would be 
affected. Hence the non-denaturing MS was carried out using the mutated construct.  
 
 
 
 
 
 63 
 
Figure 3.12 Deconvoluted ESI-MS of Saccharomyces cerevisiae RING finger. a) The denaturing 
spectrum indicates the protein with no Zn2+ ions bound at 9610 Da. b) The non-denaturing 
spectrum reveals the most abundant species at 9673 Da, indicative of the one Zn2+ ion bound to 
the protein. Traces of the protein with no Zn2+ bound were also present, but there is no evidence of 
two bound zinc ions.  
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However, a correct form of the expression construct was subsequently made and the 
sequence found to be 100 % correct (Fig. 3.4.a). The non-denaturing spectrum of the 
mutated protein yielded a mass of 9 673 Da indicative of the protein with one Zn
2+ 
bound 
(Fig. 3.12.b). A peak corresponding to no bound zinc ions (9 609 Da) was also observed; 
however there was no evidence of a peak at 9 738 Da corresponding to two bound zinc 
ions. Hence our hypothesis that this was a RING finger protein which bound only one 
zinc ion was confirmed.  
 
Evidence of +11 adducts at the 1 Zn
2+
 bound state suggests that the protein displays 
characteristics of a dimer; the reason is that the software used to deconvolute the m/z 
spectra to produce a spectrum as a function of m. It incorrectly interprets a small fraction 
of homodimers as monomers. If these homodimers contain an odd number of sodium ions 
(2n+1, where n=1, 2, 3…), then the peaks appear at ½ (2n+1) x 22 Da = (2n+1) x 11 Da. 
Such peaks can only originate from homodimers. We conclude that despite its unusual 
zinc binding characteristics, MS suggests that the ScRING still forms homodimers, 
similar to the human RING domain. However, further elucidation is needed. 
 
The presence of a significant peak corresponding to zero Zn
2+
 ions bound cannot be 
interpreted as implying that a corresponding fraction of the sample binds no zinc ions in 
solution. ESI-MS takes place in the gas phase and, although ionization conditions are as 
gentle as possible, there is still a significant likelihood of zinc ions being lost.  
 
However, the lack of any evidence at all for a second bound zinc, when compared to the 
human orthologue, can be taken as convincing evidence that only one zinc ion is bound to 
the S. cerevisiae orthologue. 
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3.4.3 Aspergillus niger RING finger 
Analysis of the sequence of the AnRING shows an aspartic acid replacing one of the zinc 
coordinating cysteines in the first pocket (Fig. 1.9). Prior to MS the AnRING was 
prepared for NMR to determine the foldedness of the protein. The good dispersion and 
sharp peaks are indicative of the AnRING being folded (Fig 3.10). This suggests that 
either the protein binds only one zinc ion (in the second pocket), or it binds 2 zinc ions in 
a CDCCC4 motif. If so, it would be the first report of a CDCCC4 motif for zinc binding. 
The denaturing mass spectrum of the AnRING shows a peak at 9 200 Da (Fig. 3.13.a), 
corresponding to the unfolded protein with no zinc ions bound. The non-denaturing MS 
shows a peak at 9 326 Da which corresponds to two bound zinc ions (Fig. 3.13.b). We 
conclude that AnRING binds 2 Zn
2+
 ions in solution, through a novel CDCC4 motif. 
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Figure 3.13 Deconvoluted ESI-MS of Aspergillus niger RING finger.  a) The denaturing ESI 
spectrum indicates the protein with no Zn2+ ions bound at 9200 Da. b) The non-denaturing 
spectrum reveals the majority of the species binding two Zn2+.  
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Chapter 4: Results - Protein-protein interactions 
 
4.1 Introduction 
Previous work conducted by Chibi et al. (2008) identified Heat shock protein 70 (Hsp70) 
as a potential interactor with RBBP6. The similarities between the structures of the RING 
domain of RBBP6 and that of U-boxes, which are found in E3 ligases associated with 
chaperone-mediated ubiquitination of unfolded proteins, suggested that the RBBP6/Hsp 
70 interaction may provide evidence for the involvement of RBBP6 in this process. The 
aim was therefore to establish an in vitro immunoprecipitation procedure with which to 
narrow down the interaction site on Hsp70, for future NMR-based studies. 
 
Human MDM2 is a highly conserved homologue of the product of the murine double 
minute (MDM2) gene (Poyurovsky et al. 2007). The primary function of MDM2 is to 
inhibit the tumor suppressor protein p53 by (i) binding to and masking the N-terminal 
transactivation domain of p52 and ii) by promoting the proteasomal degradation of p53 
(Haupt et al. 1997, in Poyurovsky et al. 2007). MDM2 acts as an E3 ligase through its 
RING finger domain, which catalyzes the transfer of ubiquitin from the E2 onto substrates 
such as p53. RBBP6 also contains a RING finger domain and has been shown to catalyze 
the ubiquitination of the mRNA-associated protein Y-Box Binding Protein (YB-1), a 
protein that is also strongly linked to tumourigenesis and chemotherapeutic resistance in 
cancers. RBBP6 has also been shown to play a role in ubiquitination of p53 and to 
interact directly with MDM2. Li et al. (2007) reported that RBBP6 cannot ubiquitinate 
p53 on its own, but potentially acts as a scaffold, positioning p53 for ubiquitination by 
MDM2. However the precise details of the interaction between RBBP6 and MDM2 are 
still unknown. 
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4.2 RBBP6 interacts with Hsp70 through its N-terminal DWNN domain 
Affinity pull-down assays were conducted to localize the interaction between RBBP6 and 
Hsp70. 6His-tagged Hsp70 and GST-tagged DWNN (RBBP1-81) were expressed in E. coli 
and 6His-affinity pull-down assays carried out, detecting with a monoclonal antibody 
against the DWNN domain as shown in Fig. 4.1.A. Hsp70 was able to precipitate the 
DWNN domain (lane 3) but two unrelated 6His-tagged proteins were not (lanes 1 and 2). 
 
When the reciprocal assay was carried out, precipitating with glutathione agarose and 
detecting with an antibody against Hsp70 (Fig. 4.1.B), RBBP6 fragments containing the 
DWNN domain were able to precipitate Hsp70 (lanes 2 and 3), but an unrelated GST-
fusion protein was not (lane 1). Lane 4 contains Hsp70 that had been subjected to 
immunoprecipitation, in order to show where it appears on an SDS-PAGE gel. 
 
4.3 Cross-linking of DWNN and Hsp70 
The next step was to identify the part of Hsp70 directly interacting with the DWNN 
domain. One method shown to be useful in this regard is cross-linking combined with 
MS. Non-covalent complexes are cross-linked using a compound such as sulfo-MBS, 
which generates NHS-ester-amino group linkages on one end and maleimide-sulfhydryl 
linkages at the other. This should manifest as higher molecular weight species on SDS-
PAGE, corresponding to the combined molecular weights of the linked proteins. The 
cross-linked species are then excised and subjected to MALDI MS in order to identify the 
identities of the cross-linked residues. This information could be used as a constraint in 
making a model of the interaction. 
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Figure 4.1 The N-terminal DWNN domain of RBBP6 interacts with Hsp70. (A) In a 6His affinity 
pull-down assay, 6His-tagged Hsp70 was able to precipitate a GST-DWNN fusion protein (lane 
3), but two unrelated His- tagged proteins were not (lanes 1-2). The same amount of DWNN 
fusion protein was present in each lane. (B) In the reciprocal GST-affinity pull-down assay, GST-
DWNN and a larger fragment of RBBP6 (including DWNN), were able to precipitate 6His-tagged 
Hsp70 (lanes 2-3), but an unrelated GST-fusion protein was not (lane 1) (Kappo et al. 2012).  
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The addition of sulfo-MBS cross-linker to a sample containing the DWNN domain and 
Hsp70 yielded a ladder of bands of molecular weight greater than Hsp70 (lanes 6 and 7) 
(Fig. 4.2a). T address this deficiency, the SDS-PAGE was Western blotted using an 
antibody raised against the DWNN domain of RBBP6. Lanes 5 and 6 of Fig. 4.2(b) show 
that species with molecular weights greater than that of Hsp70 do indeed contain the 
DWNN domain. These species are not due to DWNN-DWNN cross-linking, since they do 
not appear when only the DWNN is cross linked (Fig. 4.2. b), nor do they contain Hsp70, 
since lane 2 shows that there is no cross-reactivity between the anti-DWNN antibody and 
Hsp70. Hence we conclude that the high molecular weight bands if lanes 5 and 6 
corresponding to DWNN-Hsp70 cross-linking. 
 
4.4 MS analysis of cross-linked proteins 
 
A piece of the SDS-PAGE gel containing the high molecular weight species (indicated 
with a red rectangle in lane 6 of Fig. 4.2 (a)) was excised and subjected to liquid 
chromatography coupled to an Orbitrap Velos (Thermo Scientific, Waltham, 
Massachusetts, USA) in the laboratory of Prof. Henning Urlaub, Max Planck Institute for 
Biophysical Chemistry, Göttingen, Germany. Ionization was achieved through ESI. 
Peptides were analyzed using the cross-linking application forming part of the MASCOT 
suite. Using the sequences of the DWNN domain as Hsp70 protein as input, as well as the 
cross-linker involved, the algorithm searched the MS data for fragments of both proteins, 
as well as for intramolecular cross-linked fragments. Although the search was able to 
identify Hsp70 (Fig. 4.3), no evidence of DWNN was found.  
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Figure 4.2 Analysis of cross-linked species. a) SDS-PAGE following cross-linking of DWNN and 
Hsp70. b) Western blot of cross-linking assay using monoclonal anti-DWNN antibody. The 
addition of the hetero-bifunctional cross-linker sulfo-MBS creates high molecular weight bands 
that exceed the molecular weight of Hsp70 (70 kDa). These do not correspond to Hsp70-Hsp70 
complexes because the antibody does not recognize Hsp70 at all (lane 2) nor to DWNN-DWNN 
complexes as they do not appear to any significant content in lane 4, where DWNN alone is cross-
linked. 
 
 
 
 
 
 
 72 
 
 
Protein Mass:  33110.077 (monoisotopic)  33130.185(average)   Protein Score:    89   
Protein pp: 2149.6 Hsp 70  Sequence:AKAAAIGIDL GTTYSCVGVF QHGKVEIIAN 
DQGNRTTPSY VAFTDTERLI GDAAKNQVAL NPQNTVFDAK RLIGRKFGDP 
VVQSDMKHWP FQVINDGDKP KVQVSYKGET KAFYPEEISS MVLTKMKEIA 
EAYLGYPVTN AVITVPAYFN DSQRQATKDA GVIAGLNVLR IINEPTAAAI 
AYGLDRTGKG ERNVLIFDLG GGTFDVSILT IDDGIFEVKA TAGDTHLGGE 
DFDNRLVNHF VEEFKRKHKK DISQNKRAVR RLRTACERAK RTLSSSTQAS 
LEIDSLFEGI DFYTSITRAR 
Figure 4.3 Data generated from the Mass matrix server using the cross-linking application 
identified Hsp70 whilst no evidence of DWNN was observed, thus revealing intra-cross-links 
between the Hsp70 protein rather than inter-cross-links with DWNN.  
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While it was disappointing that mass spectrometry was unable to confirm the presence of 
the DWNN domain in the gel slice, the evidence of the Western blot in Fig. 4.2b is 
difficult to dispute. It is more likely that our search of the MS data was non-optimal and 
that it failed to identify the DWNN that was present. Further optimization of the search 
was not attempted due to time constraints. 
 
4.5 Size exclusion chromatography of DWNN and Hsp70 
In a further attempt to cross-link the DWNN domain and Hsp70, size exclusion 
chromatography was first used to isolate the interacting complex, prior to cross-linking. 
Equal concentrations of the DWNN domain and Hsp70 were mixed together and 
incubated at 4 °C before loading them on a Superdex 75 16/600 (GE healthcare, 
Pittsburgh, USA) size exclusion column. A small peak, eluting before the main Hsp70 
peak, was present only when the DWNN domain was present (Fig. 4.4.a and b.) It 
therefore represents a putative non-covalent complex between Hsp70 and the DWNN 
domain. SDS-PAGE analysis (Fig. 4.4.c) revealed a band consistent with that of the 
DWNN domain. The band was excised from the gel and subjected to tryptic digest and 
MS as before. MS confirmed that DWNN was present in the band (Fig. 4.5). Using the 
MASCOT server database to search for peptides identified yielded result for a possible 
significant hit, as RBBP6 is identified as one of the candidates identified (Fig. 4.5.a). 
Owing to the novelty of the technique hits relating to keratin and trypsin are expected. 
However, when the DWNN domain sequence is used as the input for the peptide search, 5 
peptides covering 68 % of the DWNN sequence were identified. The presence of the 
DWNN domain, which has a mass of only 9 kDa, in a fraction corresponding to a 
molecular weight of greater than 70 kDa is clear evidence that it forms a non-covalent 
interaction with Hsp70.  
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Figure 4.4 Isolation of an interacting complex between the DWNN domain and Hsp70. (a) Size 
exclusion chromatogram of Hsp70 alone. (b) Size exclusion chromatogram of DWNN and Hsp70. 
The labels refer to the lanes in (c). (c) SDS-PAGE of fractions corresponding to the fractions 
indicated in (b). The small peak eluting prior to Hsp70 contains a band consistent with the DWNN 
domain (lanes 3 and 4), which is see on its own in lane 1. The bulk of the DWNN domain elutes 
much later, consistent with its molecular weight of only 9 kDa.  
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Figure 4.5 Identification of DWNN from excised band. Using the database as the input the 
MASCOT server identified mainly keratin and trypsin (a), which are a result of sample 
preparation prior to MS. However, peptides identified match that of the RBBP6 gene. When 
subjecting the server to the DWNN domain sequence as input (b) the server identified peptides 
covering 68 % of the DWNN domain sequence (highlighted in green). 
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Further attempts to localize this interaction are currently under way, with the peptide-
binding domain of Hsp70 being the preferred candidate involved in the interaction with 
the DWNN domain. 
   
4.6 Interaction between RBBP6 and Murine-double minute 2 (MDM2) 
RBBP6 has been reported to interact directly with MDM2 in vitro (Li et al. 2007), and to 
facilitate the ubiquitination of p53 by MDM2 in a manner that requires the presence of the 
RING finger domain of RBBP6. Our unpublished data confirms that RBBP6 cooperates 
with MDM2 in the ubiquitination of p53 in in vitro ubiquitination assays, in a manner 
depending on it RING finger domain, and that it interacts directly with MDM2 in vitro 
(A. Faro and D.J.R. Pugh, unpublished data). Together this data suggests that RBBP6 and 
MDM2 may interact through their respective RING finger domains. MDM2 is known to 
heterodimerize with MDMX (through their RING finger domains (Baer & Ludwig. 
2002), and a number of other E3 ubiquitin ligases, including BRCA1 and BARD1 are 
known to do the same (Christensen & Klevit. 2009). 
 
4.6.1 Affinity pull-down assay 
 The RING finger from human RBBP6 was expressed and purified as described 
previously (Section 3). A sequence corresponding to residues 438-478 of human MDM2 
(NM_002392) was amplified from the pCMV-Myc3-HMD2 construct obtained from 
Addgene (20935) using the primers shown in Fig. 4.6. Sequencing confirmed the 
construct to be 100 % correct. The construct was expressed in E. coli and was found to be 
soluble and stable while the GST tag was still attached, although it showed evidence of 
insolubility once GST was removed using pre-scission protease.  
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Fig 4.6 Primers for amplification of MDM2-RING incorporating BamHI and XhoI restriction 
sites (red rectangles). Stop codons are indicated by the green rectangle. 
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GST-pulldown assays were conducted with GST-MDM2-RING as bait and RBBP6-
RING as prey, detecting with a polyclonal antibody against the RBBP6-RING. However, 
due to cross-reactivity between the antibody and GST-MDM2-RING, most probably due 
to the fact that the antibody had been raised using RBBP6 RING purified from a GST-
fusion construct (GST-RBBP6-RING), these assays were not pursued. 
 
As an alternative strategy, the MDM2 RING was re-amplified and cloned into the NdeI 
and XhoI sites of the pET28a vector so that it could be expressed with a C-terminal 6His 
tag (Fig. 4.7.a) The reverse primer incorporated a stop codon immediately prior to the 
XhoI site, obviating the C-terminal 6His tag (Fig. 4.7.b).  
 
Only one positive clone was obtained following the cloning of the MDM2-RING into the 
pET28a vector. Sequencing of the clone revealed a base change from adenine to guanine 
(Fig.4.8.b), which fortunately left the amino acid sequence unchanged since codons CAA 
and CAG both code for the amino acid glutamine. The MDM2-RING-His6 was found to 
express solubly and stably in E. coli. The expressed protein was kindly expressed by Dr. 
A. Faro. 
 
GST-affinity pull-down assays were conducted to establish whether an interaction exists 
between the RING finger domains of RBBP6 and MDM2, with GST-RBBP6-RING as 
bait and MDM2-RING as prey (Fig. 4.9). Western blotting was carried out using a 
monoclonal antibody recognizing an epitope within residues 383-491 of MDM2 (AB11, 
Merck Millipore, Darmstadt). Fig. 4.9 confirms that the antibody detects MDM2 (lanes 3 
and 4) but not GST-RBBP6-RING (lanes 1 and 2). GST-RBBP6-RING was able to 
precipitate MDM2-RING (lane 6), but a dummy GST-fusion protein was not (lane 5). 
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Figure 4.7 (a) Primers for amplification of MDM2-RING, incorporating an N-terminal NdeI and a 
C-terminal XhoI site (red boxes) as well as two stop codons immediately following the end of the 
gene. (b) Cloning into the NdeI and XhoI sites was chosen so as to incorporate an N-terminal 6His 
tag. Incorporation of a C-terminal 6His tag was obviated by the stop codons incorporated into the 
reverse primer. Figure adapted from http://www.staff.ncl.ac.uk/p.dean/pET.pdf, accessed 
04/07/2013. 
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Figure 4.8 a) Colony PCR screen of putative clones identified one positive colony (lane 2), which 
was subjected to sequencing. b) Comparison of the experimental sequence (Query) showed that 
the construct contained a mismatch (indicated in green). Inspection of the sequencing trace (c) 
confirmed that the mismatch was indeed present and was not due an error in base calling. 
Fortunately the mismatch was found to have no effect on the amino acid sequence. 
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Figure 4.9 GST-affinty pulldown assay using GST-RBBP6-RING as bait and MDM2-RING-6His 
as prey. MDM2-RING was detected using monoclonal antibody 4B11 against full length MDM2. 
GST-RBBP6-RING was able to pull down MDM2-RING-6His (lane 6), but a dummy GST-fusion 
was not (lane 5). 
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This important result was confirmed by replacing pull down of GST-RBBP6-RING by 
immunoprecipitation of RBBP6-RING using the polyclonal antibody discussed 
previously. Co-precipitation of MDM2-RING-6His was detected using a monoclonal antibody 
(Merck Millipore, Darmstadt, Germany). The cross-reactivity of the anti-RBBP6-RING 
polyclonal antibody mentioned earlier is not problematic in this context because the pre (MDM2-
RING) no longer incorporated a GST tag (Fig. 4.10.a). As before, MDM2-RING-6His was 
precipitated by anti-RBBP6-RING in the presence of RBBP6-RING (lane 6) but not in the 
absence of RBBP6-RING (lane 5). Alternatively, GST-RBBP6-RING was able to co-precipitate 
MDM2-RING-6His in the presence of anti-RBBP6-RING (lane 6), but not in the presence of anti-
HA (lane 4), an antibody that does not recognize RBBP6-RING. 
 
The interaction between the RING finger domains of RBBP6 and MDM2 was further confirmed 
by immunoprecipitating MDM2-RING-6His using the anti-MDM2 antibody discussed above and 
probing for co-precipitation of RBBP6-RING using the polyclonal antibody against the RBBP6-
RING (Fig. 4.10.b). Again the cross-reactivity of this antibody is not significant in this context 
because either detection of GST or of RBBP6-RING would be evidence of co-precipitation of 
RBBP6-RING by MDM2-RING-6His. Despite the poor quality of the Western blot, which is due 
to the crude nature of the anti-RBBP6-RING anti-serum, it is clear that anti-MDM2 is able to 
precipitate RBBP6-RING in the presence of MDM2-RING-6His (lane 5) but not in the absence of 
MDM2-RING-6His (lane 4). Alternatively, MDM2-RING-6His is able to precipitate RBBP6-
RING in the presence of anti-MDM2 (lane 5), but not in the presence of anti-HA, which does not 
recognize MDM2-RING-6His. 
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Figure 4.10. Co-immunoprecipitation of MDM2-RING-6His and RBBP6-RING. a) Using anti-
RBBP6-RING coupled to an Affi-gel matrix, RBBP6-RING (bait) was used to precipitate 
MDM2-RING-6His (prey) using monoclonal antibody 4B11 against full length MDM2. b) Using 
MDM2-RING-6His as bait the RBBP6-RING was precipitated, as detected using a polyclonal 
antibody against the RBBP6-RING. 
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Chapter 5: Discussion and Conclusion 
 
The aim of the project was to implement two novel mass spectrometry-based methods for 
analyzing protein function: i) non-denaturing MS to investigate zinc binding on proteins 
in their native state and ii) cross-linking mass spectrometry to investigate protein-protein 
interactions.  
 
Whereas the RING finger domain from human RBBP6 has been shown using NMR to 
bind two zinc ions, in line with all other RING fingers, analysis of the amino acid 
sequences of orthologues from S. cerevisiae and A. niger suggested that these may bind 
fewer than two zinc ions. In addition to demonstrating the power of the technique for 
analyzing proteins in their native state – unfolded proteins being unable to bind any zinc 
ions – the identification of RING finger domains binding fewer than two zinc ions would 
be of great interest in itself. In particular, it may provide support for the hypothesis 
proposed by Kappo and co-workers (Kappo et al. 2012) that the RBBP6 RING finger-like 
domains represent a structural intermediate between RING fingers and U-boxes. 
 
The non-denaturing mass spectrometry data supports the hypothesis in that it shows that 
the ScRBBP6-RING binds only one zinc ion and, based on NMR spectra, is a folded, 
presumably functional protein, thereby possibly being further stabilized by salt bridges 
and hydrogen bonds. If so, it is the first reporting of a RING finger-like domain that binds 
only one zinc ion, yet is stable and functional. The only other RING finger-like protein 
reported to bind a single zinc ion is the SP-RING domain found in members of the PIAS 
family, in which the first binding site has been lost, but the second is preserved in the 
form CHCC (Yunus & Lima, (2009)). Interestingly PIAS family proteins play the role of 
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E3 ligases for SUMO ubiquitin-like modifiers, raising the question of whether RBBP6 
may have a role in SUMOylation. 
 
There have been previous reports on RING fingers that coordinate zinc ions through an 
aspartic residue. Régnier and coworkers (1995) identified the RING finger domain of 
CART1 to have an aspartic acid in the second zinc binding pocket, thereby coordinating 
zinc in a C3HC3D motif. The sequence of the RING finger from Aspergillus niger 
suggested that one of the zinc-coordinating cysteines has been replaced with an aspartic 
acid, giving a CDCC coordination pattern in site 1 and a C4 pattern in site 2. The question 
was therefore whether site 1 would bind a zinc ion with a CDCC motif, or whether the 
protein bound only one zinc ion in site 2. Non-denaturing mass spectrometry clearly 
showed that the A. niger RING bound 2 zinc ions. It is therefore similar to the RING from 
Rbx1 and CART1, in which one of the zinc ions is coordinated by a CCCD configuration. 
However, with these two RINGs the aspartic acid is located in the second binding site for 
zinc. The AnRING has the aspartic acid in site 1, and can therefore be classified in a class 
of its own. 
 
Structural studies of the ScRING and AnRING domains using NMR would further 
substantiate the mass spectrometry data, potentially leading to re-classification of these 
RING finger-like domains as evolutionary intermediates between RING fingers and U-
boxes.  
 
Experiments pertaining to protein-protein interactions were conducted in the hope of 
localizing the regions of interaction at the amino acid level. Affinity pull-down assays 
aided in confirming the interaction between proteins, as well as partial localization, in the 
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case of RBBP6. We were able to identify the N-terminal DWNN domain of RBBP6 as the 
interacting partner of Hsp70, and hypothesized its interaction with the peptide-binding 
domain of Hsp70, as the yeast two-hybrid results published by the group (Chibi et al. 
2008) identified the peptide-binding domain of Hsp70 as the interacting partner of 
RBBP6.  
 
Initial attempts to cross-link the DWNN domain of RBBP6 and Hsp70 had failed, as the 
addition of a cross-linker yielded intra-cross-links between individual proteins, rather than 
inter-cross-links between proteins. The lack of expertise could also be attributed to the 
failure to generate good cross-linking data as the technique is novel to Africa, so 
optimization can be tedious. Owing to the novelty of the technique, software and 
algorithms too require much needed work as those currently available are beyond reach. 
However, the western blot data suggest that we have convincingly created inter-molecular 
cross-links between the DWNN domain and Hsp70. Due to time constraints the cross-
linking experiment could not be repeated as the analyzed excised band was subjected to 
MS whilst on a workshop relating to protein-protein interactions using MS. Therefore 
optimization and enrichment of cross-links could not be attempted.  
 
Using size exclusion chromatography we attempted to generate a complex between the 
DWNN domain and Hsp70, but were unsuccessful, as the complex obtained was not 
stable enough to be cross-linked. However, further work pertaining to this interaction is 
currently being pursued as the SEC and MS data conclusively provide the platform for the 
interaction to be further pursued.  
 
 
 
 
 
 
 87 
A drawback from using SEC for the complex generation is that the DWNN domain from 
RBBP6 has no tyrosine or tryptophan amino acids, so absorbance values at A280 recorded 
during SEC do not pick up the total amount of protein present. When generating a 
complex using SEC, the elution profiles of the individual proteins under scrutiny are 
aligned and compared to that of the complex elution profile. The size difference between 
the DWNN and Hsp70 is not significant enough to cause a peak shift in the elution profile 
thereby confirming the complex formation. Future work pertaining to this interaction 
would be to confirm that the peptide-binding domain from Hsp70 indeed is responsible 
for the interaction with the DWNN domain from RBBP6, produce enough quantities of 
the peptide-binding domain of Hsp70 as well as the DWNN domain, and force a complex 
between the two, before cross-linking and identifying amino acids involved in the 
interaction. 
 
The interaction between RBBP6 and Hsp70 is interesting in itself and needs much more 
attention as it implicates RBBP6 further in the stress response as well as chaperone-
mediated ubiquitination. Hsp90 has previously been identified as a potential interactor of 
RBBP6 (Witte and Scott, 1997). Owing to the function of Hsp90, which include protein 
folding and degradation, it is possible to hypothesize that RBBP6 is implicated in 
chaperone-mediated /ubiquitination, as well as pre-mRNA processing. 
 
The RING finger domain of RBBP6 has been shown to act with MDM2 during the 
process of ubiquitination (Faro, A and Pugh, DJR, unpublished data), thereby leading us 
to the hypothesis that a potential interaction might occur between the RING finger 
domains of these proteins. We can conclusively state that an interaction between RBBP6 
and MDM2 has been established through interaction of their respective RING finger 
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domains. MDM2, a homodimer, has previously been reported to heterodimerize with 
MDMX during ubiquitination. It has been reported that RBBP-RING too forms 
homodimers, as we have seen with non-denaturing ESI and NMR. This, in conjunction 
with the notion that these relatively small domains are too small to carry out a function 
independently, led to us hypothesizing that heterodimerization would enhance the 
functionality of this complex. 
 
 We attempted to form the heterodimer between RBBP6 and MDM2 using their isolated 
RING fingers. Initial results indicate that the heterodimer can be made using SEC, but 
ongoing experimentation should confirm it, thereby allowing us to perform the necessary 
experiments to try to localize their regions of interaction. Once the complex is stable 
cross-linking assays can be conducted and the interacting residues can be identified using 
MS. Validation of these interactions will be achieved through Isothermal Titration 
Calorimetery (ITC) to determine all binding parameters, or chemical shift perturbation 
experiments using NMR. Constructs with the interacting residues mutated can then be 
generated and the abolished interaction observed using NMR or ITC. 
 
 In addition, affinity purification MS (APMS) can be used in conjunction with the above 
mentioned for confirmation of the amino acids involved in the interaction.  
 
The data presented provides a building block into the workings of RBBP6, which has 
many functions, as a full-length protein, as well as individual domains of the protein. 
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